Disability weights: Difference between revisions

From Opasnet
Jump to navigation Jump to search
(→‎Result: disability weight table with table2base)
mNo edit summary
 
(14 intermediate revisions by 3 users not shown)
Line 2: Line 2:
[[Category:Costs and valuations]]
[[Category:Costs and valuations]]
[[Category: CLAIH]]
[[Category: CLAIH]]
{{variable|moderator = Virpi Kollanus
[[Category:Contains R code]]
{{method|moderator = Virpi Kollanus
|respect = 2
|respect = 2
| reference = {{publication
| reference = {{publication
Line 14: Line 15:
}}
}}


'''[[:en:Disability-adjusted life years|DALY]] weights''' describe the weights that are given to different diseases in the calculation of disability-adjusted life years.
'''Disability weights''' describe the weights that are given to different diseases in the calculation of disability-adjusted life years ([[:en:Disability-adjusted life years|DALY]]).


== Scope==
== Question==


[[:en:Disability-adjusted life years|DALY]] weight (also called: disability weight, severity weight) is a number that describes the severity of a disease. It varies from 0 (perfect health) to 1 (death).
What are disability weights for different disases, and how should they be used in calculating burden of disease?


== Definition ==  
==Answer==


=== Causality ===  
This code can be used on this page to calculate YLD (years of life under disease). The code can also be copied to another page in [[Opasnet]]. It runs on [[R]], so it is also possible to copy and use it outside the Opasnet workspace.
List of parents:
 
* No causal parents
<rcode include="page:OpasnetUtils/Summary|name:summary" variables="
name:morbidity.cases|description:How many cases of disease are there? (#)|default:1000|
name:duration|description:What is the duration of disease? (years)|default:1
">
library(OpasnetUtils)
library(xtable)
 
YLD <- new("ovariable",
name = "YLD",
dependencies = data.frame(Name = "morbidity.cases"),
formula = function(dependencies, intermediates = FALSE, ...) {
ComputeDependencies(dependencies, ...)
disability.weight <- EvalOutput(new("ovariable",
name = "disability.weight",
data = tidy(opbase.data("Op_en2307"), objname = "disability.weight") # [[Disability weights]]
))
if(!exists("duration")) {
# duration <- tidy(op_baseGetData("opasnet_base", "Op_enXXXX"), objname = "duration")
duration <- EvalOutput(new("ovariable", # This is a placeholder because actual durations are not known.
name = "duration",
data = data.frame(durationResult = 1)
))
}
 
out <- morbidity.cases * duration * disability.weight
return(out)
}
)
 
#objects.put(YLD)
#cat("Ovariable YLD has been created. Save the run key for further use.\n")
 
morbidity.cases <- new("ovariable",
name = "morbidity.cases",
data = interpret("500-1000") # data.frame(morbidity.casesResult = 1)
)
 
YLD <- EvalOutput(YLD, N = 10)
 
summary(YLD)
 
</rcode>
 
:''NOTE! Old official [http://www.who.int/entity/healthinfo/bodreferencedisabilityweights.xls WHO disability weights] were used in a [http://en.opasnet.org/en-opwiki/index.php?title=Disability_weights&oldid=26474 previous version] of this page. The current version uses disability weights from Salomon (Salomon et al., Lancet 2012-2013
<ref>Salomon JA, Vos T, Hogan DR, Gagnon M, Naghavi M et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet. 2013 Dec 15;380(9859):2129-43. {{doi|10.1016/S0140-6736(12)61680-8}}.</ref>).
 
{{disclink|Formula?}}
 
==Rationale==


=== Data ===  
=== Data ===  


Disability weights are obtained by posing two different Person Trade-Off (PTO) questions to expert panels
Disability weights are obtained by posing two different Person Trade-Off (PTO) questions to expert panels
Question 1 compares life extensions for disabled and healthy people
*Question 1 compares life extensions for disabled and healthy people
Question 2 compares cures for illness with extension of life
*Question 2 compares cures for illness with extension of life


Ideally, these values should be derived from empirical data among representative populations.
Ideally, these values should be derived from empirical data among representative populations.
Line 37: Line 89:
'''Arguments defending this approach include:'''
'''Arguments defending this approach include:'''


- DALY weights are an intrinsically subjective value for which no "true estimate" exists. They should be treated as a normative value, which does not need further uncertainty intervals.
* DALY weights are an intrinsically subjective value for which no "true estimate" exists. They should be treated as a normative value, which does not need further uncertainty intervals.
 
* Uncertainty in very small DALY weights (for less severe effects) affects overall outcomes of DALY calculations much more than uncertainty in large disability weights. This is a "flaw" of the method: if health would be defined as 1 and death as 0 (as is being done with QALYs), the more severe outcomes would have more overall uncertainty. The uncertainty is greatest for the smallest disability weights and narrows as more severe weights are attained (figure 5.16
- Uncertainty in very small DALY weights (for less severe effects) affects overall outcomes of DALY calculations much more than uncertainty in large disability weights. This is a "flaw" of the method: if health would be defined as 1 and death as 0 (as is being done with QALYs), the more severe outcomes would have more overall uncertainty. The uncertainty is greatest for the smallest disability weights and narrows as more severe weights are attained (figure 5.16<ref> Colin D. Mathers, Joshua A. Salomon, Majid Ezzati, Stephen Begg, Stephen Vander Hoorn, and Alan D. Lopez, "Sensitivity and Uncertainty Analyses for Burden of Disease and Risk Factor Estimates." 2006. Global Burden of Disease and Risk Factors,ed. , 399-426. New York: Oxford University Press. DOI: 10.1596/978-0-8213-6262-4/Chpt-5.
<ref> Colin D. Mathers, Joshua A. Salomon, Majid Ezzati, Stephen Begg, Stephen Vander Hoorn, and Alan D. Lopez, "Sensitivity and Uncertainty Analyses for Burden of Disease and Risk Factor Estimates." 2006. Global Burden of Disease and Risk Factors,ed. , 399-426. New York: Oxford University Press. DOI: 10.1596/978-0-8213-6262-4/Chpt-5.
</ref>
</ref>
).This provides a skewed image. In order to avoid this, distributions should not be used. Another solution might be to normalize the weights. {{disclink|normalizing DALY weights?}}
).This provides a skewed image. In order to avoid this, distributions should not be used. Another solution might be to normalize the weights. {{disclink|normalizing DALY weights?}}
[[Image:Severity weights.jpg]]


'''Arguments opposing this approach include:'''
'''Arguments opposing this approach include:'''


- Estimates of DALY weights differ between experts, so this variation should be presented in the overall distribution of these weights.
* Estimates of DALY weights differ between experts, so this variation should be presented in the overall distribution of these weights.


Including uncertainty intervals of disability weights will probably not affect the ranking of overall disease burden estimates very significantly (WHO GBD study). However, it will affect the confidence interval of individual estimates.
Including uncertainty intervals of disability weights will probably not affect the ranking of overall disease burden estimates very significantly (WHO GBD study). However, it will affect the confidence interval of individual estimates.
Line 60: Line 110:
*[http://www.who.int/entity/healthinfo/bodreferencedisabilityweights.xls WHO data table]
*[http://www.who.int/entity/healthinfo/bodreferencedisabilityweights.xls WHO data table]


=== Disability weights===


=== Formula ===
Comment: ICD (ICD-10) codes should be added for indexing/OH 19 May 2009


{{disclink|Formula?}}
The previous version of disability weights is [http://en.opasnet.org/en-opwiki/index.php?title=Disability_weights&oldid=26474 archived]. The data was from [http://www.who.int/entity/healthinfo/bodreferencedisabilityweights.xls] (WHO → GBD → Tools → National tools → NATIONAL BURDEN OF DISEASE SUPPLEMENTARY FILES → Disability weights [xls 313kb]).
 
*[http://www.who.int/entity/healthinfo/bodreferencedisabilityweights.xls WHO data table]
 
=== Unit ===
 
dimensionless (between 0 and 1)
 
=== References ===
<references/>
 
 
== Result  ==
 
Comment: ICD (ICD-10) codes should be added for indexing/OH 19 May 2009


The table below is from: http://www.who.int/entity/healthinfo/bodreferencedisabilityweights.xls
'''Disability weights based on IHME (Salomon et al., Lancet 13 Dec, 2012):
(WHO → GBD → Tools → National tools → NATIONAL BURDEN OF DISEASE SUPPLEMENTARY FILES → '''Disability weights [xls 313kb]''').


<t2b index="Diagnosis,Age group" locations="0-4,5-14,15-44,45-59,60+" unit="-">
<t2b index="Diagnosis" obs="Weight" unit="fraction">
HIV sero-negative cases | 0.294 | 0.294 | 0.264 | 0.274 | 0.274
Infectious disease: acute episode, mild|0.005 (0.002-0.011)
HIV sero-positive cases | 0.294 | 0.294 | 0.264 | 0.274 | 0.274
Infectious disease: acute episode, moderate|0.053 (0.033-0.081)
Syphilis, Congenital syphilis | 0.315 | 0.315 | 0.315 | 0.315 | 0.315
Infectious disease: acute episode, severe|0.210 (0.139-0.298)
Syphilis, Low birth weight | 0 | 0 | 0 | 0 | 0
Infectious disease: post-acute consequences (fatigue, emotional lability, insomnia)|0.254 (0.170-0.355)
Syphilis, Primary | 0.015 | 0.015 | 0.015 | 0.014 | 0.014
Diarrhoea: mild|0.061 (0.036-0.093)
Syphilis, Secondary | 0.048 | 0.048 | 0.048 | 0.048 | 0.044
Diarrhoea: moderate|0.202 (0.133-0.299)
Syphilis, Tertiary -- Cardiovascular | 0.196 | 0.196 | 0.196 | 0.196 | 0.196
Diarrhoea: severe|0.281 (0.184-0.399)
Syphilis, Tertiary -- Gummas | 0.102 | 0.102 | 0.102 | 0.102 | 0.094
Epididymo-orchitis|0.097 (0.063-0.137)
Syphilis, Tertiary -- Neurologic | 0.283 | 0.283 | 0.283 | 0.283 | 0.283
Herpes zoster|0.061 (0.039-0.094)
Chlamydia, Ophthalmia neonatorum | 0.18 | 0 | 0 | 0 | 0
HIV: symptomatic, pre-AIDS|0.221 (0.146-0.310)
Chlamydia, Low birth weight | 0 | 0 | 0 | 0 | 0
HIV/AIDS: receiving antiretroviral treatment|0.053 (0.034-0.079)
Chlamydia, Corneal scar -- Blindness | 0.493 | 0.491 | 0.488 | 0.488 | 0.488
AIDS: not receiving antiretroviral treatment|0.547 (0.382-0.715)
Chlamydia, Corneal scar -- Low vision | 0.223 | 0.245 | 0.245 | 0.245 | 0.245
Intestinal nematode infections: symptomatic|0.030 (0.016-0.048)
Chlamydia, Cervicitis | 0.049 | 0.049 | 0.049 | 0.049 | 0.049
Lymphatic filariasis: symptomatic|0.110 (0.073-0.157)
Chlamydia, Neonatal pneumonia | 0.28 | 0.28 | 0.276 | 0.276 | 0.28
Ear pain|0.018 (0.009-0.031)
Chlamydia, Pelvic inflammatory disease | 0.169 | 0.169 | 0.169 | 0.169 | 0.169
Tuberculosis: without HIV infection|0.331 (0.222- 0.450)
Chlamydia, Ectopic pregnancy | 0 | 0.549 | 0.549 | 0.549 | 0
Tuberculosis: with HIV infection|0.399 (0.267-0.547)
Chlamydia, Tubo-ovarian abscess | 0 | 0.549 | 0.549 | 0.549 | 0
Cancer: diagnosis and primary therapy|0.294 (0.199-0.411)
Chlamydia, Chronic pelvic pain | 0.122 | 0.122 | 0.122 | 0.122 | 0.122
Cancer: metastatic|0.484 (0.330-0.643)
Chlamydia, Infertility | 0.18 | 0.18 | 0.18 | 0.18 | 0.18
Mastectomy|0.038 (0.022-0.059)
Chlamydia, Symptomatic urethritis | 0.067 | 0.067 | 0.067 | 0.067 | 0.067
Stoma|0.086 (0.055-0.131)
Chlamydia, Epididymitis | 0.167 | 0.167 | 0.167 | 0.167 | 0.167
Terminal phase: with medication (for cancers, end-stage kidney or liver disease)|0.508 (0.348-0.670)
Chlamydia, Stricture | 0.151 | 0.151 | 0.151 | 0.151 | 0.151
Terminal phase: without medication (for cancers, end-stage kidney or liver disease)|0.519 (0.356-0.683)
Gonorrhoea, Ophthalmia neonatorum | 0.18 | 0 | 0 | 0 | 0
Acute myocardial infarction: days 1-2|0.422 (0.284-0.566)
Gonorrhoea, Low birth weight | 0 | 0 | 0 | 0 | 0
Acute myocardial infarction: days 3-28|0.056 (0.035-0.082)
Gonorrhoea, Corneal scar -- Blindness | 0.6 | 0 | 0 | 0 | 0
Angina pectoris: mild|0.037 (0.022-0.058)
Gonorrhoea, Corneal scar -- Low vision | 0.223 | 0.245 | 0.245 | 0.245 | 0.245
Angina pectoris: moderate|0.066 (0.043-0.095)
Gonorrhoea, Cervicitis | 0.049 | 0.049 | 0.049 | 0.049 | 0.049
Angina pectoris: severe|0.167 (0.109-0.234)
Gonorrhoea, Pelvic inflammatory disease | 0.169 | 0.169 | 0.169 | 0.169 | 0.169
Cardiac conduction disorders and cardiac dysrhythmias|0.145 (0.097-0.205)
Gonorrhoea, Ectopic pregnancy | 0 | 0.549 | 0.549 | 0.549 | 0
Claudication|0.016 (0.008-0.028)
Gonorrhoea, Tubo-ovarian abscess | 0 | 0.549 | 0.549 | 0.549 | 0
Heart failure: mild|0.037 (0.021-0.058)
Gonorrhoea, Chronic pelvic pain | 0.122 | 0.122 | 0.122 | 0.122 | 0.122
Heart failure: moderate|0.070 (0.044-0.102)
Gonorrhoea, Infertility | 0.18 | 0.18 | 0.18 | 0.18 | 0.18
Heart failure: severe|0.186 (0.128-0.261)
Gonorrhoea, Symptomatic urethritis | 0.067 | 0.067 | 0.067 | 0.067 | 0.067
Stroke: long-term consequences, mild|0.021 (0.011-0.037)
Gonorrhoea, Epididymitis | 0.167 | 0.167 | 0.167 | 0.167 | 0.167
Stroke: long-term consequences, moderate|0.076 (0.050-0.110)
Gonorrhoea, Stricture | 0.151 | 0.151 | 0.151 | 0.151 | 0.151
Stroke: long-term consequences, moderate plus cognition problems|0.312 (0.211-0.433)
HIV, Cases | 0.123 | 0.123 | 0.136 | 0.136 | 0.136
Stroke: long-term consequences, severe|0.539 (0.363-0.705)
HIV, AIDS | 0.505 | 0.505 | 0.505 | 0.505 | 0.505
Stroke: long-term consequences, severe plus cognition problems|0.567 (0.394-0.738)
HIV, Diarrhoeal diseases -- Episodes | 0.119 | 0.094 | 0.086 | 0.086 | 0.088
Diabetic foot|0.023 (0.012-0.039)
Pertussis, Episodes | 0 | 0 | 0 | 0 | 0
Diabetic neuropathy|0.099 (0.066-0.145)
Pertussis, Mental retardation | 0.394 | 0.42 | 0.451 | 0.466 | 0.468
Chronic kidney disease (stage IV)|0.105 (0.069-0.154)
Pertussis, Poliomyelitis -- Lameness | 0.369 | 0.369 | 0.369 | 0.369 | 0.369
End-stage renal disease: with kidney transplant|0.027 (0.015-0.043)
Diphtheria, Episodes | 0.231 | 0.23 | 0.23 | 0.23 | 0.23
End-stage renal disease: on dialysis|0.573 (0.397-0.749)
Diphtheria, Neurological complications | 0.078 | 0.078 | 0.078 | 0.078 | 0.078
Decompensated cirrhosis of the liver|0.194 (0.127-0.273)
Diphtheria, Myocarditis | 0.323 | 0.323 | 0.323 | 0.323 | 0.323
Gastric bleeding|0.323 (0.214-0.461)
Diphtheria, Measles -- Episodes | 0.152 | 0.152 | 0.152 | 0.152 | 0.152
Crohn's disease or ulcerative colitis|0.225 (0.152-0.314)
Diphtheria, Tetanus -- Episodes | 0.64 | 0.64 | 0.61 | 0.604 | 0.612
Benign prostatic hypertrophy: symptomatic|0.070 (0.046-0.102)
Bacterial meningitis, meningococcaemia, Streptococcus pneumoniae -- Episodes | 0.616 | 0.616 | 0.613 | 0.613 | 0.613
Urinary incontinence|0.142 (0.094-0.204)
Bacterial meningitis, meningococcaemia, Haemophilus influenzae -- Episodes | 0.616 | 0.616 | 0.613 | 0.613 | 0.613
Impotence|0.019 (0.010-0.034)
Bacterial meningitis, meningococcaemia, Neisseria meningitidis -- Episodes | 0.616 | 0.616 | 0.613 | 0.613 | 0.613
Infertility: primary|0.011 (0.005-0.021)
Meningococcaemia without meningitis --, Episodes | 0.152 | 0.152 | 0.152 | 0.152 | 0.152
Infertility: secondary|0.006 (0.002-0.013)
Meningococcaemia without meningitis --, Deafness | 0.175 | 0.169 | 0.168 | 0.168 | 0.168
Asthma: controlled|0.009 (0.004-0.018)
Meningococcaemia without meningitis --, Seizure disorder | 0.041 | 0.065 | 0.065 | 0.065 | 0.065
Asthma: partially controlled|0.027 (0.015-0.045)
Meningococcaemia without meningitis --, Motor deficit | 0.334 | 0.334 | 0.334 | 0.337 | 0.39
Asthma: uncontrolled|0.132 (0.087-0.190)
Meningococcaemia without meningitis --, Mental retardation | 0.394 | 0.42 | 0.451 | 0.466 | 0.468
COPD and other chronic respiratory diseases: mild|0.015 (0.007-0.028)
Meningococcaemia without meningitis --, Hepatitis B and hepatitis C -- Episodes | 0.17 | 0.181 | 0.209 | 0.212 | 0.212
COPD and other chronic respiratory diseases: moderate|0.192 (0.129-0.271)
Malaria, Episodes | 0.211 | 0.195 | 0.172 | 0.172 | 0.172
COPD and other chronic respiratory diseases: severe|0.383 (0.259-0.528)
Malaria, Anaemia | 0.012 | 0.012 | 0.012 | 0.013 | 0.012
Dementia: mild|0.082 (0.055-0.117)
Malaria, Neurological sequelae | 0.436 | 0.435 | 0.435 | 0.435 | 0.435
Dementia: moderate|0.346 (0.233-0.475)
Malaria, Trypanosomiasis -- Episodes | 0.35 | 0.35 | 0.35 | 0.35 | 0.35
Dementia: severe|0.438 (0.299-0.584)
Chagas disease, Infection | 0 | 0 | 0 | 0 | 0
Headache: migraine|0.433 (0.287-0.593)
Cardiomyopathy without congestive heart failure | 0.062 | 0.062 | 0.062 | 0.062 | 0.062
Headache: tension-type|0.040 (0.025-0.062)
Cardiomyopathy with congestive heart failure | 0.171 | 0.171 | 0.171 | 0.171 | 0.171
Multiple sclerosis: mild|0.198 (0.137-0.278)
Megaviscera | 0.24 | 0.24 | 0.24 | 0.24 | 0.24
Multiple sclerosis: moderate|0.445 (0.303-0.593)
Schistosomiasis -- Infection | 0.005 | 0.005 | 0.006 | 0.006 | 0.006
Multiple sclerosis: severe|0.707 (0.522-0.857)
Leishmaniasis, Visceral | 0.243 | 0.243 | 0.243 | 0.243 | 0.243
Epilepsy: treated, seizure free|0.072 (0.047-0.106)
Leishmaniasis, Cutaneous | 0.023 | 0.023 | 0.023 | 0.023 | 0.023
Epilepsy: treated, with recent seizures|0.319 (0.211-0.445)
Lymphatic filariasis, Hydrocele >15 cm | 0.066 | 0.07 | 0.075 | 0.075 | 0.075
Epilepsy: untreated|0.420 (0.279-0.572)
Lymphatic filariasis, Bancroftian lymphoedema | 0.067 | 0.08 | 0.113 | 0.128 | 0.119
Epilepsy: severe|0.657 (0.464-0.827)
Lymphatic filariasis, Brugian lymphoedema | 0.064 | 0.08 | 0.113 | 0.128 | 0.119
Parkinson's disease: mild|0.011 (0.005-0.021)
Onchocerciasis, Blindness | 0.493 | 0.491 | 0.488 | 0.488 | 0.488
Parkinson's disease: moderate|0.263 (0.179-0.360)
Onchocerciasis, Itching | 0.068 | 0.068 | 0.068 | 0.068 | 0.068
Parkinson's disease: severe|0.549 (0.383-0.711)
Onchocerciasis, Low vision | 0.223 | 0.245 | 0.245 | 0.245 | 0.245
Alcohol use disorder: mild|0.259 (0.176-0.359)
Leprosy, Cases | 0 | 0 | 0 | 0 | 0
Alcohol use disorder: moderate|0.388 (0.262-0.529)
Leprosy, Disabling leprosy | 0.153 | 0.153 | 0.153 | 0.153 | 0.153
Alcohol use disorder: severe|0.549 (0.384-0.708)
Dengue, Dengue haemorrhagic fever | 0.211 | 0.195 | 0.172 | 0.172 | 0.172
Fetal alcohol syndrome: mild|0.017 (0.008-0.032)
Japanese encephalitis, Episodes | 0.616 | 0.616 | 0.613 | 0.613 | 0.613
Fetal alcohol syndrome: moderate|0.057 (0.036-0.087)
Japanese encephalitis, Cognitive impairment | 0.394 | 0.42 | 0.451 | 0.466 | 0.468
Fetal alcohol syndrome: severe|0.177 (0.117-0.255)
Japanese encephalitis, Neurological sequelae | 0.334 | 0.334 | 0.334 | 0.337 | 0.39
Cannabis dependence|0.329 (0.223-0.455)
Trachoma, Blindness | 0.493 | 0.491 | 0.488 | 0.488 | 0.488
Amphetamine dependence|0.353 (0.215-0.525)
Trachoma, Low Vision | 0.223 | 0.245 | 0.245 | 0.245 | 0.245
Cocaine dependence|0.376 (0.235-0.553)
Ascariasis, High intensity infection | 0 | 0 | 0 | 0 | 0
Heroin and other opioid dependence|0.641 (0.459-0.803)
Ascariasis, Cotemporaneous cognitive deficit | 0.006 | 0.006 | 0.006 | 0.006 | 0.006
Anxiety disorders: mild|0.030 (0.017-0.048)
Ascariasis, Cognitive impairment | 0.463 | 0.463 | 0.463 | 0.463 | 0.463
Anxiety disorders: moderate|0.149 (0.101-0.210)
Ascariasis, Intestinal obstruction | 0.024 | 0.024 | 0.024 | 0.024 | 0.024
Anxiety disorders: severe|0.523 (0.365-0.684)
Trichuriasis, High intensity infection | 0 | 0 | 0 | 0 | 0
Major depressive disorder: mild episode|0.159 (0.107-0.223)
Trichuriasis, Cotemporaneous cognitive deficit | 0.006 | 0.006 | 0.006 | 0.006 | 0.006
Major depressive disorder: moderate episode|0.406 (0.276-0.551)
Trichuriasis, Massive dysentery syndrome | 0.138 | 0.116 | 0.114 | 0.114 | 0.129
Major depressive disorder: severe episode|0.655 (0.469-0.816)
Trichuriasis, Cognitive impairment | 0.024 | 0.024 | 0.024 | 0.024 | 0.024
Bipolar disorder: manic episode|0.480 (0.323-0.642)
Ancylostomiasis and necatoriasis, High intensity infection | 0 | 0 | 0 | 0 | 0
Bipolar disorder: residual state|0.035 (0.021-0.055)
Ancylostomiasis and necatoriasis, Anaemia | 0.024 | 0.024 | 0.024 | 0.024 | 0.024
Schizophrenia: acute state|0.756 (0.571-0.894)
Ancylostomiasis and necatoriasis, Cognitive impairment | 0.024 | 0.024 | 0.024 | 0.024 | 0.024
Schizophrenia: residual state|0.576 (0.399-0.756)
Lower respiratory infections, Episodes | 0.28 | 0.28 | 0.276 | 0.276 | 0.28
Anorexia nervosa|0.223 (0.151-0.313)
Lower respiratory infections, Chronic sequelae | 0.099 | 0.099 | 0.099 | 0.099 | 0.099
Bulimia nervosa|0.223 (0.150-0.310)
Upper respiratory infections, Episodes | 0 | 0 | 0 | 0 | 0
Attention-deficit hyperactivity disorder|0.049 (0.031-0.074)
Upper respiratory infections, Pharyngitis | 0.07 | 0.07 | 0.07 | 0.07 | 0.07
Conduct disorder|0.236 (0.154-0.337)
Otitis media, Episodes | 0.023 | 0.023 | 0.023 | 0.023 | 0.023
Asperger's syndrome|0.110 (0.073-0.157)
Otitis media, Deafness | 0.175 | 0.169 | 0.168 | 0.168 | 0.168
Autism|0.259 (0.177-0.362)
Maternal haemorrhage, Episodes | 0 | 0 | 0 | 0 | 0
Intellectual disability: mild|0.031 (0.018-0.049)
Maternal haemorrhage, Sheehan syndrome | 0.065 | 0.065 | 0.065 | 0.065 | 0.065
Intellectual disability: moderate|0.080 (0.053-0.114)
Maternal haemorrhage, Severe anaemia | 0.087 | 0.087 | 0.093 | 0.09 | 0.087
Intellectual disability: severe|0.126 (0.085-0.176)
Maternal sepsis, Episodes | 0 | 0 | 0 | 0 | 0
Intellectual disability: profound|0.157 (0.107-0.221)
Maternal sepsis, Infertility | 0 | 0 | 0.18 | 0 | 0
Hearing loss: mild|0.005 (0.002-0.012)
Hypertensive disorders of pregnancy, Episodes | 0 | 0 | 0 | 0 | 0
Hearing loss: moderate|0.023 (0.013-0.038)
Hypertensive disorders of pregnancy, Neurological sequelae | 0.388 | 0.388 | 0.388 | 0.397 | 0.468
Hearing loss: severe|0.032 (0.018-0.051)
Obstructed labour, Episodes | 0 | 0 | 0 | 0 | 0
Hearing loss: profound|0.031 (0.018-0.049)
Obstructed labour, Stress incontinence | 0.025 | 0.025 | 0.025 | 0.025 | 0.033
Hearing loss: complete|0.033 (0.020-0.052)
Obstructed labour, Rectovaginal fistula | 0 | 0 | 0.43 | 0 | 0
Hearing loss: mild, with ringing|0.038 (0.024-0.058)
Abortion, Episodes | 0 | 0 | 0 | 0 | 0
Hearing loss: moderate, with ringing|0.058 (0.037-0.085)
Abortion, Infertility | 0 | 0 | 0.18 | 0 | 0
Hearing loss: severe, with ringing|0.065 (0.041-0.094)
Abortion, Low birth weight -- All sequelae | 0.256 | 0.256 | 0.256 | 0.256 | 0.256
Hearing loss: profound, with ringing|0.088 (0.058-0.127)
Birth asphyxia and birth trauma -- All sequelae | 0.334 | 0.334 | 0.334 | 0.334 | 0.334
Hearing loss: complete, with ringing|0.092 (0.061-0.134)
Protein-energy malnutrition, Wasting | 0.053 | 0 | 0 | 0 | 0
Distance vision: mild impairment|0.004 (0.001-0.010)
Protein-energy malnutrition, Stunting | 0.002 | 0 | 0 | 0 | 0
Distance vision: moderate impairment|0.033 (0.020-0.052)
Protein-energy malnutrition, Developmental disability | 0.024 | 0.024 | 0.024 | 0.024 | 0.024
Distance vision: severe impairment|0.191 (0.129-0.269)
Iodine deficiency, Goitre -- grade 0 | 0 | 0 | 0 | 0 | 0
Distance vision blindness|0.195 (0.132-0.272)
Iodine deficiency, Goitre -- grade 1 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001
Near vision impairment|0.013 (0.006-0.024)
Iodine deficiency, Goitre -- grade 2 | 0.025 | 0.025 | 0.025 | 0.025 | 0.025
Low back pain: acute, without leg pain|0.269 (0.184-0.373)
Iodine deficiency, Mild developmental disability | 0.006 | 0.006 | 0.006 | 0.006 | 0.006
Low back pain: acute, with leg pain|0.322 (0.219-0.447)
Iodine deficiency, Cretinoidism | 0.255 | 0.255 | 0.255 | 0.255 | 0.255
Low back pain: chronic, without leg pain|0.366 (0.248-0.499)
Iodine deficiency, Cretinism | 0.804 | 0.804 | 0.804 | 0.804 | 0.804
Low back pain: chronic, with leg pain|0.374 (0.252-0.506)
Vitamin A deficiency, Xerophthalmia | 0 | 0 | 0 | 0 | 0
Neck pain: acute, mild|0.040 (0.023-0.064)
Vitamin A deficiency, Corneal scar | 0.274 | 0.282 | 0.282 | 0.282 | 0.282
Neck pain: acute, severe|0.221 (0.150-0.305)
Iron-deficiency anaemia, Mild | 0 | 0 | 0 | 0 | 0
Neck pain: chronic, mild|0.101 (0.067-0.149)
Iron-deficiency anaemia, Moderate | 0.011 | 0.011 | 0.011 | 0.012 | 0.012
Neck pain: chronic, severe|0.286 (0.197-0.398)
Iron-deficiency anaemia, Severe | 0.087 | 0.087 | 0.093 | 0.09 | 0.087
Musculoskeletal problems: legs, mild|0.023 (0.013-0.039)
Iron-deficiency anaemia, Very severe | 0.241 | 0.244 | 0.255 | 0.252 | 0.252
Musculoskeletal problems: legs, moderate|0.079 (0.053-0.115)
Iron-deficiency anaemia, Cognitive impairment | 0.024 | 0.024 | 0.024 | 0.024 | 0.024
Musculoskeletal problems: legs, severe|0.171 (0.117-0.240)
Cancers -- Preterminal, Mouth and oropharynx | 0.09 | 0.09 | 0.09 | 0.09 | 0.09
Musculoskeletal problems: arms, mild|0.024 (0.014-0.041)
Cancers -- Preterminal, Oesophagus | 0.217 | 0.217 | 0.217 | 0.217 | 0.217
Musculoskeletal problems: arms, moderate|0.114 (0.077-0.159)
Cancers -- Preterminal, Stomach | 0.217 | 0.217 | 0.217 | 0.217 | 0.217
Musculoskeletal problems: generalised, moderate|0.292 (0.197-0.410)
Cancers -- Preterminal, Colon and rectum | 0.217 | 0.217 | 0.217 | 0.217 | 0.217
Musculoskeletal problems: generalised, severe|0.606 (0.421-0.771)
Cancers -- Preterminal, Liver | 0.239 | 0.239 | 0.239 | 0.239 | 0.239
Gout: acute|0.293 (0.198-0.404)
Cancers -- Preterminal, Pancreas | 0.237 | 0.237 | 0.237 | 0.237 | 0.237
Amputation of finger(s), excluding thumb: long term, with treatment|0.030 (0.018-0.048)
Cancers -- Preterminal, Trachea, bronchus and lung | 0.146 | 0.146 | 0.146 | 0.146 | 0.146
Amputation of thumb: long term|0.013 (0.006-0.025)
Cancers -- Preterminal, Melanoma and other skin | 0.045 | 0.045 | 0.045 | 0.045 | 0.045
Amputation of one arm: long term, with or without treatment|0.130 (0.088-0.185)
Cancers -- Preterminal, Breast | 0.086 | 0.086 | 0.086 | 0.086 | 0.086
Amputation of both arms: long term, with treatment|0.044 (0.028-0.067)
Cancers -- Preterminal, Cervix uteri | 0.075 | 0.075 | 0.075 | 0.075 | 0.075
Amputation of both arms: long term, without treatment|0.359 (0.242-0.497)
Cancers -- Preterminal, Corpus uteri | 0.099 | 0.104 | 0.104 | 0.096 | 0.079
Amputation of toe|0.008 (0.003-0.017)
Cancers -- Preterminal, Ovary | 0.097 | 0.097 | 0.097 | 0.084 | 0.059
Amputation of one leg: long term, withtreatment|0.021 (0.011-0.035)
Cancers -- Preterminal, Prostate | 0.134 | 0.134 | 0.134 | 0.134 | 0.134
Amputation of one leg: long term, without treatment|0.164 (0.111-0.229)
Cancers -- Preterminal, Bladder | 0.087 | 0.087 | 0.087 | 0.087 | 0.085
Amputation of both legs: long term, with treatment|0.051 (0.032-0.076)
Cancers -- Preterminal, Lymphomas and multiple myeloma | 0.057 | 0.057 | 0.057 | 0.057 | 0.057
Amputation of both legs: long term, without treatment|0.494 (0.341-0.654)
Cancers -- Preterminal, Leukaemia | 0.083 | 0.083 | 0.093 | 0.097 | 0.097
Burns of <20% total surface area without lower airway burns: short term, with or without treatment|0.096 (0.062-0.140)
Cancers -- terminal, | 0.809 | 0.809 | 0.809 | 0.809 | 0.809
Burns of <20% total surface area or <10% total surface area if head or neck, or hands or wrist involved: long term, with or without treatment|0.018 (0.010-0.032)
Diabetes mellitus, Cases | 0.033 | 0.033 | 0.033 | 0.033 | 0.033
Burns of ≥20% total surface area: short term, with or without treatment|0.333 (0.220-0.472)
Diabetes mellitus, Diabetic foot | 0.129 | 0.129 | 0.129 | 0.129 | 0.129
Burns of ≥20% total surface area or ≥10% total surface area if head or neck, or hands or wrist involved: long term, with treatment|0.127 (0.086-0.183)
Diabetes mellitus, Neuropathy | 0.064 | 0.064 | 0.064 | 0.064 | 0.064
Burns of ≥20% total surface area or ≥10% total surface area if head or neck, or hands or wrist involved: long term, without treatment|0.438 (0.298-0.588)
Diabetes mellitus, Retinopathy -- Blindness | 0.493 | 0.491 | 0.488 | 0.488 | 0.488
Lower airway burns: with or without treatment|0.373 (0.248-0.521)
Diabetes mellitus, Amputation | 0.068 | 0.068 | 0.068 | 0.068 | 0.068
Crush injury: short or long term, with or without treatment|0.145 (0.093-0.211)
Diabetes mellitus, Unipolar major depression -- episodes | 0.302 | 0.302 | 0.302 | 0.302 | 0.302
Dislocation of hip: long term, with or without treatment|0.017 (0.008-0.030)
Diabetes mellitus, Bipolar disorder -- Cases | 0.383 | 0.383 | 0.383 | 0.383 | 0.383
Dislocation of knee: long term, with or without treatment|0.129 (0.087-0.178)
Diabetes mellitus, Schizophrenia -- Cases | 0.351 | 0.351 | 0.351 | 0.351 | 0.351
Dislocation of shoulder: long term, with or without treatment|0.080 (0.053-0.116)
Diabetes mellitus, Epilepsy -- Cases | 0.041 | 0.065 | 0.065 | 0.065 | 0.065
Other injuries of muscle and tendon (includes sprains, strains, and dislocations other than shoulder, knee, or hip)|0.009 (0.004-0.018)
Diabetes mellitus, Alcohol use -- | 0.18 | 0.18 | 0.18 | 0.18 | 0.18
Drowning and non-fatal submersion: short or long term, with or without treatment|0.288 (0.191-0.403)
Diabetes mellitus, Alcohol dependence syndrome | 0.18 | 0.18 | 0.18 | 0.18 | 0.18
Fracture of clavicle, scapula, or humerus: short or long term, with or without treatment|0.053 (0.033-0.080)
Diabetes mellitus, Dementia -- Cases | 0.627 | 0.627 | 0.627 | 0.645 | 0.667
Fracture of face bone: short or long term, with or without treatment|0.173 (0.111- 0.257)
Diabetes mellitus, Parkinson disease -- Cases | 0.316 | 0.316 | 0.316 | 0.316 | 0.332
Fracture of foot bones: short term, with or without treatment|0.033 (0.019-0.053)
Diabetes mellitus, Multiple sclerosis -- Cases | 0.41 | 0.41 | 0.41 | 0.42 | 0.437
Fracture of foot bones: long term, without treatment|0.033 (0.019-0.052)
Drug use -- Dysfunctional and harmful drug use | 0.252 | 0.252 | 0.25 | 0.25 | 0.25
Fracture of hand: short term, with or without treatment|0.025 (0.013-0.043)
Drug use -- Post-traumatic stress disorder -- Cases | 0.105 | 0.105 | 0.108 | 0.108 | 0.108
Fracture of hand: long term, without treatment|0.016 (0.008-0.028)
Obsessive-compulsive disorders --, Cases | 0.08 | 0.08 | 0.08 | 0.08 | 0.08
Fracture of neck of femur: short term, with or without treatment|0.308 (0.205-0.439)
Obsessive-compulsive disorders --, Panic disorder -- Cases | 0.091 | 0.091 | 0.091 | 0.091 | 0.091
Fracture of neck of femur: long term, with treatment|0.072 (0.047-0.105)
Obsessive-compulsive disorders --, Glaucoma -- Blindness | 0.6 | 0.6 | 0.6 | 0.6 | 0.6
Fracture of neck of femur: long term, without treatment|0.388 (0.261-0.532)
Obsessive-compulsive disorders --, Cataracts -- Blindness | 0.493 | 0.491 | 0.488 | 0.488 | 0.488
Fracture other than neck of femur: short term, with or without treatment|0.192 (0.121-0.280)
Rheumatic heart disease --, Congestive heart failure | 0.171 | 0.171 | 0.171 | 0.171 | 0.171
Fracture other than neck of femur: long term, without treatment|0.053 (0.035-0.079)
Ischaemic heart disease, Acute myocardial infarction | 0.395 | 0.395 | 0.395 | 0.395 | 0.395
Fracture of patella, tibia or fibula, or ankle: short term, with or without treatment|0.087 (0.055-0.127)
Ischaemic heart disease, Angina pectoris | 0.095 | 0.095 | 0.095 | 0.095 | 0.095
Fracture of patella, tibia or fibula, or ankle: long term, with or without treatment|0.070 (0.047-0.102)
Ischaemic heart disease, Congestive heart failure | 0.171 | 0.171 | 0.171 | 0.171 | 0.171
Fracture of pelvis: short term|0.390 (0.257-0.545)
Cerebrovascular disease --, First-ever stroke | 0.224 | 0.224 | 0.224 | 0.224 | 0.258
Fracture of pelvis: long term|0.194 (0.132-0.272)
Inflammatory heart diseases, Myocarditis | 0.171 | 0.171 | 0.171 | 0.171 | 0.171
Fracture of radius or ulna: short term, with or without treatment|0.065 (0.040-0.101)
Inflammatory heart diseases, Pericarditis | 0.171 | 0.171 | 0.171 | 0.171 | 0.171
Fracture of radius or ulna: long term, without treatment|0.050 (0.032-0.075)
Inflammatory heart diseases, Endocarditis | 0.171 | 0.171 | 0.171 | 0.171 | 0.171
Fracture of skull: short or long term, with or without treatment|0.073 (0.046-0.109)
Inflammatory heart diseases, Cardiomyopathy | 0.171 | 0.171 | 0.171 | 0.171 | 0.171
Fracture of sternum or fracture of one or two ribs: short term, with or without treatment|0.150 (0.098-0.215)
Inflammatory heart diseases, COPD -- Symptomatic cases | 0.388 | 0.388 | 0.388 | 0.388 | 0.388
Fracture of vertebral column: short or long term, with or without treatment|0.132 (0.085-0.195)
Inflammatory heart diseases, Asthma -- Cases | 0.059 | 0.059 | 0.059 | 0.059 | 0.059
Fractures: treated, long term|0.003 (0.001-0.008)
Inflammatory heart diseases, Peptic ulcer -- Cases | 0.003 | 0.003 | 0.003 | 0.003 | 0.003
Injured nerves: short term|0.065 (0.040-0.096)
Cirrhosis of the liver --, Symptomatic cases | 0.33 | 0.33 | 0.33 | 0.33 | 0.33
Injured nerves: long term|0.136 (0.092-0.189)
Cirrhosis of the liver --, Appendicitis -- Episodes | 0.463 | 0.463 | 0.463 | 0.463 | 0.463
Injury to eyes: short term|0.079 (0.050-0.118)
Nephritis and nephrosis, Acute glomerulonephritis | 0.107 | 0.107 | 0.107 | 0.096 | 0.096
Severe traumatic brain injury: short term, with or without treatment|0.235 (0.156-0.331)
Nephritis and nephrosis, End-stage renal disease | 0.107 | 0.107 | 0.107 | 0.096 | 0.096
Traumatic brain injury: long-term consequences, minor, with or without treatment|0.106 (0.072-0.147)
Benign prostatic hypertrophy --, Symptomatic cases | 0.038 | 0.038 | 0.038 | 0.038 | 0.038
Traumatic brain injury: long-term consequences, moderate, with or without treatment|0.224 (0.153-0.314)
Benign prostatic hypertrophy --, Rheumatoid arthritis -- Cases | 0.174 | 0.174 | 0.174 | 0.174 | 0.174
Traumatic brain injury: long-term consequences, severe, with or without treatment|0.625 (0.444-0.789)
Osteoarthritis, Hip | 0.108 | 0.108 | 0.108 | 0.108 | 0.108
Open wound: short term, with or without treatment|0.005 (0.002-0.013)
Osteoarthritis, Knee | 0.108 | 0.108 | 0.108 | 0.108 | 0.108
Poisoning: short term, with or without treatment|0.171 (0.116-0.239)
Congenital anomalies, Abdominal wall defect -- Cases | 0.85 | 0 | 0 | 0 | 0
Severe chest injury: long term, with or without treatment|0.056 (0.036-0.082)
Congenital anomalies, Anencephaly -- Cases | 0.85 | 0 | 0 | 0 | 0
Severe chest injury: short term, with or without treatment|0.352 (0.229-0.484)
Congenital anomalies, Anorectal atresia -- Cases | 0.85 | 0 | 0 | 0 | 0
Spinal cord lesion below neck: treated|0.047 (0.029-0.072)
Congenital anomalies, Cleft lip -- Cases | 0.016 | 0 | 0 | 0 | 0
Spinal cord lesion below neck: untreated|0.440 (0.290-0.588)
Congenital anomalies, Cleft palate -- Cases | 0.015 | 0 | 0 | 0 | 0
Spinal cord lesion at neck: treated|0.369 (0.243-0.513)
Congenital anomalies, Oesophageal atresia -- Cases | 0.85 | 0 | 0 | 0 | 0
Spinal cord lesion at neck: untreated|0.673 (0.475-0.837)
Congenital anomalies, Renal agenesis -- Cases | 0.85 | 0 | 0 | 0 | 0
Abdominopelvic problem: mild|0.012 (0.005-0.023)
Congenital anomalies, Down syndrome -- Cases | 0.593 | 0.593 | 0.593 | 0.593 | 0.593
Abdominopelvic problem: moderate|0.123 (0.083-0.176)
Congenital anomalies, Congenital heart anomalies -- Cases | 0.323 | 0.323 | 0.323 | 0.323 | 0.323
Abdominopelvic problem: severe|0.326 (0.219-0.451)
Congenital anomalies, Spina bifida -- Cases | 0.593 | 0.593 | 0.593 | 0.593 | 0.593
Anaemia: mild|0.005 (0.002-0.011)
Congenital anomalies, Dental caries -- Episodes | 0.081 | 0.081 | 0.081 | 0.081 | 0.081
Anaemia: moderate|0.058 (0.038-0.086)
Congenital anomalies, Periodontal disease -- Episodes | 0.001 | 0.001 | 0.001 | 0.001 | 0.001
Anaemia: severe|0.164 (0.112-0.228)
Congenital anomalies, Edentulism -- Cases | 0.001 | 0.001 | 0.001 | 0.001 | 0.001
Periodontitis|0.008 (0.003-0.017)
Drownings, Episodes | 0 | 0 | 0 | 0 | 0
Dental caries: symptomatic|0.012 (0.005-0.023)
Drownings, Quadriplegia | 0.005 | 0.005 | 0.005 | 0.005 | 0.005
Severe tooth loss|0.072 (0.048-0.103)
Drownings, Poisoning -- Episodes | 0.611 | 0.611 | 0.607 | 0.607 | 0.607
Disfigurement: level 1|0.013 (0.006-0.025)
Fractures, Skull -- Short term | 0.431 | 0.431 | 0.431 | 0.431 | 0.431
Disfigurement: level 2|0.072 (0.048-0.103)
Fractures, Skull -- Long term | 0.35 | 0.35 | 0.35 | 0.35 | 0.404
Disfigurement: level 3|0.398 (0.271-0.543)
Fractures, Face bones | 0.223 | 0.223 | 0.223 | 0.223 | 0.223
Disfigurement: level 1 with itch or pain|0.029 (0.016-0.048)
Fractures, Vertebral column | 0.266 | 0.266 | 0.266 | 0.266 | 0.266
Disfigurement: level 2, with itch or pain|0.187 (0.125-0.264)
Fractures, Injured spinal cord | 0.725 | 0.725 | 0.725 | 0.725 | 0.725
Disfigurement: level 3, with itch or pain|0.562 (0.394-0.725)
Fractures, Rib or sternum | 0.199 | 0.199 | 0.199 | 0.199 | 0.199
Generic uncomplicated disease: worry and daily medication|0.031 (0.017-0.050)
Fractures, Pelvis | 0.247 | 0.247 | 0.247 | 0.247 | 0.247
Generic uncomplicated disease: anxiety about diagnosis|0.054 (0.033-0.082)
Fractures, Clavicle, scapula, or humerus | 0.153 | 0.153 | 0.137 | 0.137 | 0.137
Iodine-deficiency goitre|0.200 (0.134-0.283)
Fractures, Radius or ulna | 0.18 | 0.18 | 0.18 | 0.18 | 0.18
Kwashiorkor|0.055 (0.033-0.085)
Fractures, Hand bones | 0.1 | 0.1 | 0.1 | 0.1 | 0.1
Severe wasting|0.127 (0.081-0.183)
Fractures, Femur -- Short term | 0.372 | 0.372 | 0.372 | 0.372 | 0.372
Speech problems|0.054 (0.034-0.081)
Fractures, Femur -- Long term | 0.272 | 0.272 | 0.272 | 0.272 | 0.272
Motor impairment: mild|0.012 (0.005-0.022)
Fractures, Patella, tibia, or fibula | 0.271 | 0.271 | 0.271 | 0.271 | 0.271
Motor impairment: moderate|0.076 (0.050-0.109)
Fractures, Ankle | 0.196 | 0.196 | 0.196 | 0.196 | 0.196
Motor impairment: severe|0.377 (0.251-0.518)
Fractures, Foot bones | 0.077 | 0.077 | 0.077 | 0.077 | 0.077
Motor plus cognitive impairments: mild|0.054 (0.033-0.084)
Fractures, Dislocated shoulder, elbow, or hip | 0.074 | 0.074 | 0.074 | 0.074 | 0.074
Motor plus cognitive impairments: moderate|0.221 (0.141-0.314)
Fractures, Sprains | 0.064 | 0.064 | 0.064 | 0.064 | 0.064
Motor plus cognitive impairments: severe|0.425 (0.286-0.587)
Intracranial injury, Short term | 0.359 | 0.359 | 0.359 | 0.359 | 0.359
Rectovaginal fistula|0.492 (0.330-0.660)
Intracranial injury, Long term | 0.359 | 0.359 | 0.359 | 0.359 | 0.359
Vesicovaginal fistula|0.338 (0.228-0.467)
Intracranial injury, Internal injuries | 0.208 | 0.208 | 0.208 | 0.208 | 0.208
Intracranial injury, Open wound | 0.108 | 0.108 | 0.108 | 0.108 | 0.108
Intracranial injury, Injury to eyes | 0.301 | 0.3 | 0.299 | 0.299 | 0.299
Amputations, Thumb | 0.165 | 0.165 | 0.165 | 0.165 | 0.165
Amputations, Finger | 0.102 | 0.102 | 0.102 | 0.102 | 0.102
Amputations, Arm | 0.102 | 0.102 | 0.102 | 0.102 | 0.102
Amputations, Toe | 0.064 | 0.064 | 0.064 | 0.064 | 0.064
Amputations, Foot | 0.3 | 0.3 | 0.3 | 0.3 | 0.3
Amputations, Leg | 0.3 | 0.3 | 0.3 | 0.3 | 0.3
Amputations, Crushing | 0.218 | 0.218 | 0.218 | 0.218 | 0.218
Burns, <20% -- Short term | 0.158 | 0.158 | 0.158 | 0.158 | 0.158
Burns, <20% -- Long term | 0.011 | 0.011 | 0.011 | 0.011 | 0.011
Burns, >20% and <60% -- Short term | 0.441 | 0.441 | 0.441 | 0.441 | 0.441
Burns, >20% and <60% -- Long term | 0.255 | 0.255 | 0.255 | 0.255 | 0.255
Burns, >60% -- Short term | 0.441 | 0.441 | 0.441 | 0.441 | 0.441
Burns, >60% -- Long term | 0.255 | 0.255 | 0.255 | 0.255 | 0.255
Burns, Injured nerves | 0.064 | 0.064 | 0.064 | 0.064 | 0.064
</t2b>
</t2b>


== See also  ==


{| {{prettytable}}
* [[Global Burden of Disease Study]]
|+ '''Annex Table 3. Age-specific disability weights for untreated and treated forms of sequelae included in the Global Burden of Disease Study.
* [[Disability-adjusted life years]]
|-
* [[:en:Disability-adjusted life year|Disability-adjusted life year]] in Wikipedia
|
*WHO report describing DALYs and presents disability weights: Murray CJL, Lopez AD, eds. 1996. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Cambridge, Harvard School of Public Health on behalf of the World Health Organization and the World Bank.  
! colspan="5" | Untreated form
*An update of the disability weights [http://www.who.int/healthinfo/global_burden_disease/GBD2004_DisabilityWeights.pdf]
|
*Data by regions (European), for example YLD (years of life lived with the disease) [http://www.who.int/healthinfo/global_burden_disease/estimates_regional/en/]
! colspan="5" | Treated form
*Dutch disability weights [http://www.rivm.nl/vtv/object_document/o1676n18840.html] (Available only in Dutch)
|-
*[[Severity weights for noise outcomes]]
! Diagnosis
! colspan="5" | Age group (years)
|
! colspan="5" | Age group (years)
|-
| Sequela
| 0-4
| 5-14
| 15-44
| 45-59
| 60+
|
| 0-4
| 5-14
| 15-44
| 45-59
| 60+
|-
| Tuberculosis
|
|
|
|
|
|
|
|
|
|
|
|-
| HIV sero-negative cases
| 0.294
| 0.294
| 0.264
| 0.274
| 0.274
|
| 0.294
| 0.294
| 0.264
| 0.274
| 0.274
|-
| HIV sero-positive cases
| 0.294
| 0.294
| 0.264
| 0.274
| 0.274
|
| 0.294
| 0.294
| 0.264
| 0.274
| 0.274
|-
| Syphilis
|
|
|
|
|
|
|
|
|
|
|
|-
| Congenital syphilis
| 0.315
| 0.315
| 0.315
| 0.315
| 0.315
|
| 0.315
| 0.315
| 0.315
| 0.315
| 0.315
|-
| Low birth weight
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Primary
| 0.015
| 0.015
| 0.015
| 0.014
| 0.014
|
| 0.015
| 0.015
| 0.015
| 0.014
| 0.014
|-
| Secondary
| 0.048
| 0.048
| 0.048
| 0.048
| 0.044
|
| 0.048
| 0.048
| 0.048
| 0.048
| 0.044
|-
| Tertiary -- Cardiovascular
| 0.196
| 0.196
| 0.196
| 0.196
| 0.196
|
| 0.196
| 0.196
| 0.196
| 0.196
| 0.196
|-
| Tertiary -- Gummas
| 0.102
| 0.102
| 0.102
| 0.102
| 0.094
|
| 0.102
| 0.102
| 0.102
| 0.102
| 0.094
|-
| Tertiary -- Neurologic
| 0.283
| 0.283
| 0.283
| 0.283
| 0.283
|
| 0.283
| 0.283
| 0.283
| 0.283
| 0.283
|-
| Chlamydia
|
|
|
|
|
|
|
|
|
|
|
|-
| Ophthalmia neonatorum
| 0.180
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.180
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Low birth weight
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Corneal scar -- Blindness
| 0.600
| 0.600
| 0.600
| 0.600
| 0.600
|
| 0.493
| 0.491
| 0.488
| 0.488
| 0.488
|-
| Corneal scar -- Low vision
| 0.223
| 0.245
| 0.245
| 0.245
| 0.245
|
| 0.223
| 0.245
| 0.245
| 0.245
| 0.245
|-
| Cervicitis
| 0.049
| 0.049
| 0.049
| 0.049
| 0.049
|
| 0.049
| 0.049
| 0.049
| 0.049
| 0.049
|-
| Neonatal pneumonia
| 0.280
| 0.280
| 0.276
| 0.276
| 0.280
|
| 0.280
| 0.280
| 0.276
| 0.276
| 0.280
|-
| Pelvic inflammatory disease  
| 0.420
| 0.420
| 0.420
| 0.420
| 0.420
|
| 0.169
| 0.169
| 0.169
| 0.169
| 0.169
|-
| Ectopic pregnancy
| 0.000
| 0.549
| 0.549
| 0.549
| 0.000
|
| 0.000
| 0.549
| 0.549
| 0.549
| 0.000
|-
| Tubo-ovarian abscess
| 0.000
| 0.549
| 0.549
| 0.549
| 0.000
|
| 0.000
| 0.549
| 0.549
| 0.549
| 0.000
|-
| Chronic pelvic pain
| 0.122
| 0.122
| 0.122
| 0.122
| 0.122
|
| 0.122
| 0.122
| 0.122
| 0.122
| 0.122
|-
| Infertility
| 0.180
| 0.180
| 0.180
| 0.180
| 0.180
|
| 0.180
| 0.180
| 0.180
| 0.180
| 0.180
|-
| Symptomatic urethritis
| 0.067
| 0.067
| 0.067
| 0.067
| 0.067
|
| 0.067
| 0.067
| 0.067
| 0.067
| 0.067
|-
| Epididymitis
| 0.167
| 0.167
| 0.167
| 0.167
| 0.167
|
| 0.167
| 0.167
| 0.167
| 0.167
| 0.167
|-
| Stricture
| 0.151
| 0.151
| 0.151
| 0.151
| 0.151
|
| 0.151
| 0.151
| 0.151
| 0.151
| 0.151
|-
| Gonorrhoea
|
|
|
|
|
|
|
|
|
|
|
|-
| Ophthalmia neonatorum
| 0.180
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.180
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Low birth weight
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Corneal scar -- Blindness
| 0.600
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.600
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Corneal scar -- Low vision
| 0.223
| 0.245
| 0.245
| 0.245
| 0.245
|
| 0.223
| 0.245
| 0.245
| 0.245
| 0.245
|-
| Cervicitis
| 0.049
| 0.049
| 0.049
| 0.049
| 0.049
|
| 0.049
| 0.049
| 0.049
| 0.049
| 0.049
|-
| Pelvic inflammatory disease
| 0.169
| 0.169
| 0.169
| 0.169
| 0.169
|
| 0.169
| 0.169
| 0.169
| 0.169
| 0.169
|-
| Ectopic pregnancy
| 0.000
| 0.549
| 0.549
| 0.549
| 0.000
|
| 0.000
| 0.549
| 0.549
| 0.549
| 0.000
|-
| Tubo-ovarian abscess
| 0.000
| 0.549
| 0.549
| 0.549
| 0.000
|
| 0.000
| 0.549
| 0.549
| 0.549
| 0.000
|-
| Chronic pelvic pain
| 0.122
| 0.122
| 0.122
| 0.122
| 0.122
|
| 0.122
| 0.122
| 0.122
| 0.122
| 0.122
|-
| Infertility
| 0.180
| 0.180
| 0.180
| 0.180
| 0.180
|
| 0.180
| 0.180
| 0.180
| 0.180
| 0.180
|-
| Symptomatic urethritis
| 0.067
| 0.067
| 0.067
| 0.067
| 0.067
|
| 0.067
| 0.067
| 0.067
| 0.067
| 0.067
|-
| Epididymitis
| 0.167
| 0.167
| 0.167
| 0.167
| 0.167
|
| 0.167
| 0.167
| 0.167
| 0.167
| 0.167
|-
| Stricture
| 0.151
| 0.151
| 0.151
| 0.151
| 0.151
|
| 0.151
| 0.151
| 0.151
| 0.151
| 0.151
|-
| HIV
|
|
|
|
|
|
|
|
|
|
|
|-
| Cases
| 0.123
| 0.123
| 0.136
| 0.136
| 0.136
|
| 0.123
| 0.123
| 0.136
| 0.136
| 0.136
|-
| AIDS
| 0.505
| 0.505
| 0.505
| 0.505
| 0.505
|
| 0.505
| 0.505
| 0.505
| 0.505
| 0.505
|-
| Diarrhoeal diseases -- Episodes
| 0.119
| 0.094
| 0.086
| 0.086
| 0.088
|
| 0.119
| 0.094
| 0.086
| 0.086
| 0.088
|-
| Pertussis
|
|
|
|
|
|
|
|
|
|
|
|-
| Episodes
| 0.178
| 0.166
| 0.156
| 0.156
| 0.156
|
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Mental retardation
| 0.469
| 0.483
| 0.483
| 0.486
| 0.485
|
| 0.394
| 0.420
| 0.451
| 0.466
| 0.468
|-
| Poliomyelitis -- Lameness
| 0.369
| 0.369
| 0.369
| 0.369
| 0.369
|
| 0.369
| 0.369
| 0.369
| 0.369
| 0.369
|-
| Diphtheria
|
|
|
|
|
|
|
|
|
|
|
|-
| Episodes
| 0.231
| 0.230
| 0.230
| 0.230
| 0.230
|
| 0.231
| 0.230
| 0.230
| 0.230
| 0.230
|-
| Neurological complications
| 0.078
| 0.078
| 0.078
| 0.078
| 0.078
|
| 0.078
| 0.078
| 0.078
| 0.078
| 0.078
|-
| Myocarditis
| 0.323
| 0.323
| 0.323
| 0.323
| 0.323
|
| 0.323
| 0.323
| 0.323
| 0.323
| 0.323
|-
| Measles -- Episodes
| 0.152
| 0.152
| 0.152
| 0.152
| 0.152
|
| 0.152
| 0.152
| 0.152
| 0.152
| 0.152
|-
| Tetanus -- Episodes
| 0.640
| 0.640
| 0.610
| 0.604
| 0.612
|
| 0.640
| 0.640
| 0.610
| 0.604
| 0.612
|-
| Bacterial meningitis, meningococcaemia
|
|
|
|
|
|
|
|
|
|
|
|-
| Streptococcus pneumoniae -- Episodes
| 0.616
| 0.616
| 0.613
| 0.613
| 0.613
|
| 0.616
| 0.616
| 0.613
| 0.613
| 0.613
|-
| Haemophilus influenzae -- Episodes
| 0.616
| 0.616
| 0.613
| 0.613
| 0.613
|
| 0.616
| 0.616
| 0.613
| 0.613
| 0.613
|-
| Neisseria meningitidis -- Episodes
| 0.616
| 0.616
| 0.613
| 0.613
| 0.613
|
| 0.616
| 0.616
| 0.613
| 0.613
| 0.613
|-
| Meningococcaemia without meningitis --
|
|
|
|
|
|
|
|
|
|
|-
| Episodes
| 0.152
| 0.152
| 0.152
| 0.152
| 0.152
|
| 0.152
| 0.152
| 0.152
| 0.152
| 0.152
|-
| Deafness
| 0.233
| 0.227
| 0.216
| 0.215
| 0.213
|
| 0.175
| 0.169
| 0.168
| 0.168
| 0.168
|-
| Seizure disorder
| 0.099
| 0.150
| 0.150
| 0.150
| 0.150
|
| 0.041
| 0.065
| 0.065
| 0.065
| 0.065
|-
| Motor deficit
| 0.388
| 0.388
| 0.388
| 0.397
| 0.468
|
| 0.334
| 0.334
| 0.334
| 0.337
| 0.390
|-
| Mental retardation
| 0.469
| 0.483
| 0.483
| 0.486
| 0.485
|
| 0.394
| 0.420
| 0.451
| 0.466
| 0.468
|-
| Hepatitis B and hepatitis C -- Episodes
| 0.170
| 0.181
| 0.209
| 0.212
| 0.212
|
| 0.170
| 0.181
| 0.209
| 0.212
| 0.212
|-
| Malaria
|
|
|
|
|
|
|
|
|
|
|
|-
| Episodes
| 0.211
| 0.195
| 0.172
| 0.172
| 0.172
|
| 0.211
| 0.195
| 0.172
| 0.172
| 0.172
|-
| Anaemia
| 0.012
| 0.012
| 0.012
| 0.013
| 0.012
|
| 0.012
| 0.012
| 0.012
| 0.013
| 0.012
|-
| Neurological sequelae
| 0.473
| 0.473
| 0.473
| 0.473
| 0.473
|
| 0.436
| 0.435
| 0.435
| 0.435
| 0.435
|-
| Trypanosomiasis -- Episodes
| 0.350
| 0.350
| 0.350
| 0.350
| 0.350
|
| 0.350
| 0.350
| 0.350
| 0.350
| 0.350
|-
| Chagas disease
|
|
|
|
|
|
|
|
|
|
|
|-
| Infection
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Cardiomyopathy without congestive
|
|
|
|
|
|
|
|
|
|
|-
| heart failure
| 0.062
| 0.062
| 0.062
| 0.062
| 0.062
|
| 0.062
| 0.062
| 0.062
| 0.062
| 0.062
|-
| Cardiomyopathy with congestive
|
|
|
|
|
|
|
|
|
|
|-
| heart failure
| 0.323
| 0.323
| 0.323
| 0.323
| 0.323
|
| 0.171
| 0.171
| 0.171
| 0.171
| 0.171
|-
| Megaviscera
| 0.240
| 0.240
| 0.240
| 0.240
| 0.240
|
| 0.240
| 0.240
| 0.240
| 0.240
| 0.240
|-
| Schistosomiasis -- Infection
| 0.005
| 0.005
| 0.006
| 0.006
| 0.006
|
| 0.005
| 0.005
| 0.006
| 0.006
| 0.006
|-
| Leishmaniasis
|
|
|
|
|
|
|
|
|
|
|
|-
| Visceral
| 0.243
| 0.243
| 0.243
| 0.243
| 0.243
|
| 0.243
| 0.243
| 0.243
| 0.243
| 0.243
|-
| Cutaneous
| 0.023
| 0.023
| 0.023
| 0.023
| 0.023
|
| 0.023
| 0.023
| 0.023
| 0.023
| 0.023
|-
| Lymphatic filariasis
|
|
|
|
|
|
|
|
|
|
|
|-
| Hydrocele &gt;15 cm
| 0.066
| 0.070
| 0.075
| 0.075
| 0.075
|
| 0.066
| 0.070
| 0.075
| 0.075
| 0.075
|-
| Bancroftian lymphoedema
| 0.067
| 0.080
| 0.113
| 0.128
| 0.119
|
| 0.067
| 0.080
| 0.113
| 0.128
| 0.119
|-
| Brugian lymphoedema
| 0.064
| 0.080
| 0.113
| 0.128
| 0.119
|
| 0.064
| 0.080
| 0.113
| 0.128
| 0.119
|-
| Onchocerciasis
|
|
|
|
|
|
|
|
|
|
|
|-
| Blindness
| 0.600
| 0.600
| 0.600
| 0.600
| 0.600
|
| 0.493
| 0.491
| 0.488
| 0.488
| 0.488
|-
| Itching
| 0.068
| 0.068
| 0.068
| 0.068
| 0.068
|
| 0.068
| 0.068
| 0.068
| 0.068
| 0.068
|-
| Low vision
| 0.223
| 0.245
| 0.245
| 0.245
| 0.245
|
| 0.223
| 0.245
| 0.245
| 0.245
| 0.245
|-
| Leprosy
|
|
|
|
|
|
|
|
|
|
|
|-
| Cases
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Disabling leprosy
| 0.153
| 0.153
| 0.153
| 0.153
| 0.153
|
| 0.153
| 0.153
| 0.153
| 0.153
| 0.153
|-
| Dengue
|
|
|
|
|
|
|
|
|
|
|
|-
| Dengue haemorrhagic fever
| 0.211
| 0.195
| 0.172
| 0.172
| 0.172
|
| 0.211
| 0.195
| 0.172
| 0.172
| 0.172
|-
| Japanese encephalitis
|
|
|
|
|
|
|
|
|
|
|
|-
| Episodes
| 0.616
| 0.616
| 0.613
| 0.613
| 0.613
|
| 0.616
| 0.616
| 0.613
| 0.613
| 0.613
|-
| Cognitive impairment
| 0.469
| 0.483
| 0.483
| 0.486
| 0.485
|
| 0.394
| 0.420
| 0.451
| 0.466
| 0.468
|-
| Neurological sequelae
| 0.388
| 0.388
| 0.388
| 0.397
| 0.468
|
| 0.334
| 0.334
| 0.334
| 0.337
| 0.390
|-
| Trachoma
|
|
|
|
|
|
|
|
|
|
|
|-
| Blindness
| 0.600
| 0.600
| 0.600
| 0.600
| 0.600
|
| 0.493
| 0.491
| 0.488
| 0.488
| 0.488
|-
| Low Vision
| 0.223
| 0.245
| 0.245
| 0.245
| 0.245
|
| 0.223
| 0.245
| 0.245
| 0.245
| 0.245
|-
| Ascariasis
|
|
|
|
|
|
|
|
|
|
|
|-
| High intensity infection
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Cotemporaneous cognitive deficit
| 0.006
| 0.006
| 0.006
| 0.006
| 0.006
|
| 0.006
| 0.006
| 0.006
| 0.006
| 0.006
|-
| Cognitive impairment
| 0.463
| 0.463
| 0.463
| 0.463
| 0.463
|
| 0.463
| 0.463
| 0.463
| 0.463
| 0.463
|-
| Intestinal obstruction
| 0.024
| 0.024
| 0.024
| 0.024
| 0.024
|
| 0.024
| 0.024
| 0.024
| 0.024
| 0.024
|-
| Trichuriasis
|
|
|
|
|
|
|
|
|
|
|
|-
| High intensity infection
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Cotemporaneous cognitive deficit
| 0.006
| 0.006
| 0.006
| 0.006
| 0.006
|
| 0.006
| 0.006
| 0.006
| 0.006
| 0.006
|-
| Massive dysentery syndrome
| 0.138
| 0.116
| 0.114
| 0.114
| 0.129
|
| 0.138
| 0.116
| 0.114
| 0.114
| 0.129
|-
| Cognitive impairment
| 0.024
| 0.024
| 0.024
| 0.024
| 0.024
|
| 0.024
| 0.024
| 0.024
| 0.024
| 0.024
|-
| Ancylostomiasis and necatoriasis
|
|
|
|
|
|
|
|
|
|
|
|-
| High intensity infection
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Anaemia
| 0.024
| 0.024
| 0.024
| 0.024
| 0.024
|
| 0.024
| 0.024
| 0.024
| 0.024
| 0.024
|-
| Cognitive impairment
| 0.024
| 0.024
| 0.024
| 0.024
| 0.024
|
| 0.024
| 0.024
| 0.024
| 0.024
| 0.024
|-
| Lower respiratory infections
|
|
|
|
|
|
|
|
|
|
|
|-
| Episodes
| 0.280
| 0.280
| 0.276
| 0.276
| 0.280
|
| 0.280
| 0.280
| 0.276
| 0.276
| 0.280
|-
| Chronic sequelae
| 0.099
| 0.099
| 0.099
| 0.099
| 0.099
|
| 0.099
| 0.099
| 0.099
| 0.099
| 0.099
|-
| Upper respiratory infections
|
|
|
|
|
|
|
|
|
|
|
|-
| Episodes
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Pharyngitis
| 0.070
| 0.070
| 0.070
| 0.070
| 0.070
|
| 0.070
| 0.070
| 0.070
| 0.070
| 0.070
|-
| Otitis media
|
|
|
|
|
|
|
|
|
|
|
|-
| Episodes
| 0.023
| 0.023
| 0.023
| 0.023
| 0.023
|
| 0.023
| 0.023
| 0.023
| 0.023
| 0.023
|-
| Deafness
| 0.233
| 0.227
| 0.216
| 0.215
| 0.213
|
| 0.175
| 0.169
| 0.168
| 0.168
| 0.168
|-
| Maternal haemorrhage
|
|
|
|
|
|
|
|
|
|
|
|-
| Episodes
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Sheehan syndrome
| 0.065
| 0.065
| 0.065
| 0.065
| 0.065
|
| 0.065
| 0.065
| 0.065
| 0.065
| 0.065
|-
| Severe anaemia
| 0.087
| 0.087
| 0.093
| 0.090
| 0.087
|
| 0.087
| 0.087
| 0.093
| 0.090
| 0.087
|-
| Maternal sepsis
|
|
|
|
|
|
|
|
|
|
|
|-
| Episodes
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Infertility
| 0.000
| 0.000
| 0.180
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.180
| 0.000
| 0.000
|-
| Hypertensive disorders of pregnancy
|
|
|
|
|
|
|
|
|
|
|
|-
| Episodes
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Neurological sequelae
| 0.388
| 0.388
| 0.388
| 0.397
| 0.468
|
| 0.388
| 0.388
| 0.388
| 0.397
| 0.468
|-
| Obstructed labour
|
|
|
|
|
|
|
|
|
|
|
|-
| Episodes
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Stress incontinence
| 0.025
| 0.025
| 0.025
| 0.025
| 0.033
|
| 0.025
| 0.025
| 0.025
| 0.025
| 0.033
|-
| Rectovaginal fistula
| 0.000
| 0.000
| 0.430
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.430
| 0.000
| 0.000
|-
| Abortion
|
|
|
|
|
|
|
|
|
|
|
|-
| Episodes
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Infertility
| 0.000
| 0.000
| 0.180
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.180
| 0.000
| 0.000
|-
| Low birth weight -- All sequelae
| 0.291
| 0.291
| 0.291
| 0.291
| 0.291
|
| 0.256
| 0.256
| 0.256
| 0.256
| 0.256
|-
| Birth asphyxia and birth trauma --
|
|
|
|
|
|
|
|
|
|
|
|-
| All sequelae
| 0.381
| 0.381
| 0.381
| 0.381
| 0.381
|
| 0.334
| 0.334
| 0.334
| 0.334
| 0.334
|-
| Protein-energy malnutrition
|
|
|
|
|
|
|
|
|
|
|
|-
| Wasting
| 0.053
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.053
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Stunting
| 0.002
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.002
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Developmental disability  
| 0.024
| 0.024
| 0.024
| 0.024
| 0.024
|
| 0.024
| 0.024
| 0.024
| 0.024
| 0.024
|-
| Iodine deficiency
|
|
|
|
|
|
|
|
|
|
|
|-
| Goitre -- grade 0
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Goitre -- grade 1
| 0.001
| 0.001
| 0.001
| 0.001
| 0.001
|
| 0.001
| 0.001
| 0.001
| 0.001
| 0.001
|-
| Goitre -- grade 2
| 0.025
| 0.025
| 0.025
| 0.025
| 0.025
|
| 0.025
| 0.025
| 0.025
| 0.025
| 0.025
|-
| Mild developmental disability
| 0.006
| 0.006
| 0.006
| 0.006
| 0.006
|
| 0.006
| 0.006
| 0.006
| 0.006
| 0.006
|-
| Cretinoidism
| 0.255
| 0.255
| 0.255
| 0.255
| 0.255
|
| 0.255
| 0.255
| 0.255
| 0.255
| 0.255
|-
| Cretinism
| 0.804
| 0.804
| 0.804
| 0.804
| 0.804
|
| 0.804
| 0.804
| 0.804
| 0.804
| 0.804
|-
| Vitamin A deficiency
|
|
|
|
|
|
|
|
|
|
|
|-
| Xerophthalmia
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Corneal scar
| 0.274
| 0.282
| 0.282
| 0.282
| 0.282
|
| 0.274
| 0.282
| 0.282
| 0.282
| 0.282
|-
| Iron-deficiency anaemia
|
|
|
|
|
|
|
|
|
|
|
|-
| Mild
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Moderate
| 0.011
| 0.011
| 0.011
| 0.012
| 0.012
|
| 0.011
| 0.011
| 0.011
| 0.012
| 0.012
|-
| Severe
| 0.087
| 0.087
| 0.093
| 0.090
| 0.087
|
| 0.087
| 0.087
| 0.093
| 0.090
| 0.087
|-
| Very severe
| 0.241
| 0.244
| 0.255
| 0.252
| 0.252
|
| 0.241
| 0.244
| 0.255
| 0.252
| 0.252
|-
| Cognitive impairment
| 0.024
| 0.024
| 0.024
| 0.024
| 0.024
|
| 0.024
| 0.024
| 0.024
| 0.024
| 0.024
|-
| Cancers -- Preterminal
|
|
|
|
|
|
|
|
|
|
|
|-
| Mouth and oropharynx
| 0.145
| 0.145
| 0.145
| 0.145
| 0.145
|
| 0.090
| 0.090
| 0.090
| 0.090
| 0.090
|-
| Oesophagus
| 0.217
| 0.217
| 0.217
| 0.217
| 0.217
|
| 0.217
| 0.217
| 0.217
| 0.217
| 0.217
|-
| Stomach
| 0.217
| 0.217
| 0.217
| 0.217
| 0.217
|
| 0.217
| 0.217
| 0.217
| 0.217
| 0.217
|-
| Colon and rectum
| 0.217
| 0.217
| 0.217
| 0.217
| 0.217
|
| 0.217
| 0.217
| 0.217
| 0.217
| 0.217
|-
| Liver
| 0.239
| 0.239
| 0.239
| 0.239
| 0.239
|
| 0.239
| 0.239
| 0.239
| 0.239
| 0.239
|-
| Pancreas
| 0.301
| 0.301
| 0.301
| 0.301
| 0.301
|
| 0.237
| 0.237
| 0.237
| 0.237
| 0.237
|-
| Trachea, bronchus and lung
| 0.146
| 0.146
| 0.146
| 0.146
| 0.146
|
| 0.146
| 0.146
| 0.146
| 0.146
| 0.146
|-
| Melanoma and other skin
| 0.045
| 0.045
| 0.045
| 0.045
| 0.045
|
| 0.045
| 0.045
| 0.045
| 0.045
| 0.045
|-
| Breast
| 0.069
| 0.069
| 0.069
| 0.069
| 0.069
|
| 0.086
| 0.086
| 0.086
| 0.086
| 0.086
|-
| Cervix uteri
| 0.066
| 0.066
| 0.066
| 0.066
| 0.066
|
| 0.075
| 0.075
| 0.075
| 0.075
| 0.075
|-
| Corpus uteri
| 0.066
| 0.066
| 0.066
| 0.066
| 0.066
|
| 0.099
| 0.104
| 0.104
| 0.096
| 0.079
|-
| Ovary
| 0.081
| 0.081
| 0.081
| 0.081
| 0.081
|
| 0.097
| 0.097
| 0.097
| 0.084
| 0.059
|-
| Prostate
| 0.113
| 0.113
| 0.113
| 0.113
| 0.113
|
| 0.134
| 0.134
| 0.134
| 0.134
| 0.134
|-
| Bladder
| 0.085
| 0.085
| 0.085
| 0.085
| 0.085
|
| 0.087
| 0.087
| 0.087
| 0.087
| 0.085
|-
| Lymphomas and multiple myeloma
| 0.089
| 0.089
| 0.089
| 0.089
| 0.089
|
| 0.057
| 0.057
| 0.057
| 0.057
| 0.057
|-
| Leukaemia
| 0.098
| 0.098
| 0.108
| 0.112
| 0.112
|
| 0.083
| 0.083
| 0.093
| 0.097
| 0.097
|-
| Cancers -- Terminal
| 0.809
| 0.809
| 0.809
| 0.809
| 0.809
|
| 0.809
| 0.809
| 0.809
| 0.809
| 0.809
|-
| Diabetes mellitus
|
|
|
|
|
|
|
|
|
|
|
|-
| Cases
| 0.012
| 0.012
| 0.012
| 0.012
| 0.012
|
| 0.033
| 0.033
| 0.033
| 0.033
| 0.033
|-
| Diabetic foot
| 0.137
| 0.137
| 0.137
| 0.137
| 0.137
|
| 0.129
| 0.129
| 0.129
| 0.129
| 0.129
|-
| Neuropathy
| 0.078
| 0.078
| 0.078
| 0.078
| 0.078
|
| 0.064
| 0.064
| 0.064
| 0.064
| 0.064
|-
| Retinopathy -- Blindness
| 0.600
| 0.600
| 0.600
| 0.600
| 0.600
|
| 0.493
| 0.491
| 0.488
| 0.488
| 0.488
|-
| Amputation
| 0.155
| 0.155
| 0.155
| 0.155
| 0.155
|
| 0.068
| 0.068
| 0.068
| 0.068
| 0.068
|-
| Unipolar major depression -- episodes
| 0.600
| 0.600
| 0.600
| 0.600
| 0.600
|
| 0.302
| 0.302
| 0.302
| 0.302
| 0.302
|-
| Bipolar disorder -- Cases
| 0.583
| 0.583
| 0.583
| 0.583
| 0.583
|
| 0.383
| 0.383
| 0.383
| 0.383
| 0.383
|-
| Schizophrenia -- Cases
| 0.627
| 0.627
| 0.627
| 0.645
| 0.667
|
| 0.351
| 0.351
| 0.351
| 0.351
| 0.351
|-
| Epilepsy -- Cases
| 0.099
| 0.150
| 0.150
| 0.150
| 0.150
|
| 0.041
| 0.065
| 0.065
| 0.065
| 0.065
|-
| Alcohol use --
| 0.180
| 0.180
| 0.180
| 0.180
| 0.180
|
| 0.180
| 0.180
| 0.180
| 0.180
| 0.180
|-
| Alcohol dependence syndrome
| 0.180
| 0.180
| 0.180
| 0.180
| 0.180
|
| 0.180
| 0.180
| 0.180
| 0.180
| 0.180
|-
| Dementia -- Cases
| 0.627
| 0.627
| 0.627
| 0.645
| 0.667
|
| 0.627
| 0.627
| 0.627
| 0.645
| 0.667
|-
| Parkinson disease -- Cases
| 0.392
| 0.392
| 0.392
| 0.392
| 0.406
|
| 0.316
| 0.316
| 0.316
| 0.316
| 0.332
|-
| Multiple sclerosis -- Cases
| 0.410
| 0.410
| 0.410
| 0.420
| 0.437
|
| 0.410
| 0.410
| 0.410
| 0.420
| 0.437
|-
| Drug use --
|
|
|
|
|
|
|
|
|
|
|
|-
| Dysfunctional and harmful drug use
| 0.252
| 0.252
| 0.250
| 0.250
| 0.250
|
| 0.252
| 0.252
| 0.250
| 0.250
| 0.250
|-
| Post-traumatic stress disorder -- Cases
| 0.105
| 0.105
| 0.108
| 0.108
| 0.108
|
| 0.105
| 0.105
| 0.108
| 0.108
| 0.108
|-
| Obsessive-compulsive disorders --
|
|
|
|
|
|
|
|
|
|
|
|-
| Cases
| 0.129
| 0.129
| 0.129
| 0.129
| 0.129
|
| 0.080
| 0.080
| 0.080
| 0.080
| 0.080
|-
| Panic disorder -- Cases
| 0.173
| 0.173
| 0.173
| 0.173
| 0.173
|
| 0.091
| 0.091
| 0.091
| 0.091
| 0.091
|-
| Glaucoma -- Blindness
| 0.600
| 0.600
| 0.600
| 0.600
| 0.600
|
| 0.600
| 0.600
| 0.600
| 0.600
| 0.600
|-
| Cataracts -- Blindness
| 0.600
| 0.600
| 0.600
| 0.600
| 0.600
|
| 0.493
| 0.491
| 0.488
| 0.488
| 0.488
|-
| Rheumatic heart disease --
|
|
|
|
|
|
|
|
|
|
|
|-
| Congestive heart failure
| 0.323
| 0.323
| 0.323
| 0.323
| 0.323
|
| 0.171
| 0.171
| 0.171
| 0.171
| 0.171
|-
| Ischaemic heart disease
|
|
|
|
|
|
|
|
|
|
|
|-
| Acute myocardial infarction
| 0.491
| 0.491
| 0.491
| 0.491
| 0.491
|
| 0.395
| 0.395
| 0.395
| 0.395
| 0.395
|-
| Angina pectoris
| 0.227
| 0.227
| 0.227
| 0.227
| 0.227
|
| 0.095
| 0.095
| 0.095
| 0.095
| 0.095
|-
| Congestive heart failure
| 0.323
| 0.323
| 0.323
| 0.323
| 0.323
|
| 0.171
| 0.171
| 0.171
| 0.171
| 0.171
|-
| Cerebrovascular disease --
|
|
|
|
|
|
|
|
|
|
|
|-
| First-ever stroke
| 0.262
| 0.262
| 0.262
| 0.268
| 0.301
|
| 0.224
| 0.224
| 0.224
| 0.224
| 0.258
|-
| Inflammatory heart diseases
|
|
|
|
|
|
|
|
|
|
|
|-
| Myocarditis
| 0.323
| 0.323
| 0.323
| 0.323
| 0.323
|
| 0.171
| 0.171
| 0.171
| 0.171
| 0.171
|-
| Pericarditis
| 0.323
| 0.323
| 0.323
| 0.323
| 0.323
|
| 0.171
| 0.171
| 0.171
| 0.171
| 0.171
|-
| Endocarditis
| 0.323
| 0.323
| 0.323
| 0.323
| 0.323
|
| 0.171
| 0.171
| 0.171
| 0.171
| 0.171
|-
| Cardiomyopathy
| 0.323
| 0.323
| 0.323
| 0.323
| 0.323
|
| 0.171
| 0.171
| 0.171
| 0.171
| 0.171
|-
| COPD -- Symptomatic cases
| 0.428
| 0.428
| 0.428
| 0.428
| 0.428
|
| 0.388
| 0.388
| 0.388
| 0.388
| 0.388
|-
| Asthma -- Cases
| 0.099
| 0.099
| 0.099
| 0.099
| 0.099
|
| 0.059
| 0.059
| 0.059
| 0.059
| 0.059
|-
| Peptic ulcer -- Cases
| 0.115
| 0.115
| 0.115
| 0.115
| 0.115
|
| 0.003
| 0.003
| 0.003
| 0.003
| 0.003
|-
| Cirrhosis of the liver --
|
|
|
|
|
|
|
|
|
|
|
|-
| Symptomatic cases
| 0.330
| 0.330
| 0.330
| 0.330
| 0.330
|
| 0.330
| 0.330
| 0.330
| 0.330
| 0.330
|-
| Appendicitis -- Episodes
| 0.463
| 0.463
| 0.463
| 0.463
| 0.463
|
| 0.463
| 0.463
| 0.463
| 0.463
| 0.463
|-
| Nephritis and nephrosis
|
|
|
|
|
|
|
|
|
|
|
|-
| Acute glomerulonephritis
| 0.082
| 0.082
| 0.104
| 0.104
| 0.104
|
| 0.107
| 0.107
| 0.107
| 0.096
| 0.096
|-
| End-stage renal disease  
| 0.082
| 0.082
| 0.104
| 0.104
| 0.104
|
| 0.107
| 0.107
| 0.107
| 0.096
| 0.096
|-
| Benign prostatic hypertrophy --
|
|
|
|
|
|
|
|
|
|
|
|-
| Symptomatic cases
| 0.038
| 0.038
| 0.038
| 0.038
| 0.038
|
| 0.038
| 0.038
| 0.038
| 0.038
| 0.038
|-
| Rheumatoid arthritis -- Cases
| 0.233
| 0.233
| 0.233
| 0.233
| 0.233
|
| 0.174
| 0.174
| 0.174
| 0.174
| 0.174
|-
| Osteoarthritis
|
|
|
|
|
|
|
|
|
|
|
|-
| Hip
| 0.156
| 0.156
| 0.156
| 0.156
| 0.156
|
| 0.108
| 0.108
| 0.108
| 0.108
| 0.108
|-
| Knee
| 0.156
| 0.156
| 0.156
| 0.156
| 0.156
|
| 0.108
| 0.108
| 0.108
| 0.108
| 0.108
|-
| Congenital anomalies
|
|
|
|
|
|
|
|
|
|
|
|-
| Abdominal wall defect -- Cases
| 0.850
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.850
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Anencephaly -- Cases
| 0.850
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.850
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Anorectal atresia -- Cases
| 0.850
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.850
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Cleft lip -- Cases
| 0.098
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.016
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Cleft palate -- Cases
| 0.231
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.015
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Oesophageal atresia -- Cases
| 0.850
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.850
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Renal agenesis -- Cases
| 0.850
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.850
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Down syndrome -- Cases
| 0.593
| 0.593
| 0.593
| 0.593
| 0.593
|
| 0.593
| 0.593
| 0.593
| 0.593
| 0.593
|-
| Congenital heart anomalies -- Cases
| 0.323
| 0.323
| 0.323
| 0.323
| 0.323
|
| 0.323
| 0.323
| 0.323
| 0.323
| 0.323
|-
| Spina bifida -- Cases
| 0.593
| 0.593
| 0.593
| 0.593
| 0.593
|
| 0.593
| 0.593
| 0.593
| 0.593
| 0.593
|-
| Dental caries -- Episodes
| 0.081
| 0.081
| 0.081
| 0.081
| 0.081
|
| 0.081
| 0.081
| 0.081
| 0.081
| 0.081
|-
| Periodontal disease -- Episodes
| 0.001
| 0.001
| 0.001
| 0.001
| 0.001
|
| 0.001
| 0.001
| 0.001
| 0.001
| 0.001
|-
| Edentulism -- Cases
| 0.061
| 0.061
| 0.061
| 0.061
| 0.061
|
| 0.001
| 0.001
| 0.001
| 0.001
| 0.001
|-
| Drownings
|
|
|
|
|
|
|
|
|
|
|
|-
| Episodes
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Quadriplegia
| 0.005
| 0.005
| 0.005
| 0.005
| 0.005
|
| 0.005
| 0.005
| 0.005
| 0.005
| 0.005
|-
| Poisoning -- Episodes
| 0.611
| 0.611
| 0.607
| 0.607
| 0.607
|
| 0.611
| 0.611
| 0.607
| 0.607
| 0.607
|-
| Fractures
|
|
|
|
|
|
|
|
|
|
|
|-
| Skull -- Short term
| 0.431
| 0.431
| 0.431
| 0.431
| 0.431
|
| 0.431
| 0.431
| 0.431
| 0.431
| 0.431
|-
| Skull -- Long term
| 0.411
| 0.411
| 0.411
| 0.410
| 0.395
|
| 0.350
| 0.350
| 0.350
| 0.350
| 0.404
|-
| Face bones
| 0.223
| 0.223
| 0.223
| 0.223
| 0.223
|
| 0.223
| 0.223
| 0.223
| 0.223
| 0.223
|-
| Vertebral column
| 0.266
| 0.266
| 0.266
| 0.266
| 0.266
|
| 0.266
| 0.266
| 0.266
| 0.266
| 0.266
|-
| Injured spinal cord
| 0.725
| 0.725
| 0.725
| 0.725
| 0.725
|
| 0.725
| 0.725
| 0.725
| 0.725
| 0.725
|-
| Fractures
|
|
|
|
|
|
|
|
|
|
|
|-
| Rib or sternum
| 0.199
| 0.199
| 0.199
| 0.199
| 0.199
|
| 0.199
| 0.199
| 0.199
| 0.199
| 0.199
|-
| Pelvis
| 0.247
| 0.247
| 0.247
| 0.247
| 0.247
|
| 0.247
| 0.247
| 0.247
| 0.247
| 0.247
|-
| Clavicle, scapula, or humerus
| 0.153
| 0.153
| 0.137
| 0.137
| 0.137
|
| 0.153
| 0.153
| 0.137
| 0.137
| 0.137
|-
| Radius or ulna
| 0.180
| 0.180
| 0.180
| 0.180
| 0.180
|
| 0.180
| 0.180
| 0.180
| 0.180
| 0.180
|-
| Hand bones
| 0.100
| 0.100
| 0.100
| 0.100
| 0.100
|
| 0.100
| 0.100
| 0.100
| 0.100
| 0.100
|-
| Femur -- Short term
| 0.372
| 0.372
| 0.372
| 0.372
| 0.372
|
| 0.372
| 0.372
| 0.372
| 0.372
| 0.372
|-
| Femur -- Long term
| 0.272
| 0.272
| 0.272
| 0.272
| 0.272
|
| 0.272
| 0.272
| 0.272
| 0.272
| 0.272
|-
| Patella, tibia, or fibula
| 0.271
| 0.271
| 0.271
| 0.271
| 0.271
|
| 0.271
| 0.271
| 0.271
| 0.271
| 0.271
|-
| Ankle
| 0.196
| 0.196
| 0.196
| 0.196
| 0.196
|
| 0.196
| 0.196
| 0.196
| 0.196
| 0.196
|-
| Foot bones
| 0.077
| 0.077
| 0.077
| 0.077
| 0.077
|
| 0.077
| 0.077
| 0.077
| 0.077
| 0.077
|-
| Dislocated shoulder, elbow, or hip
| 0.074
| 0.074
| 0.074
| 0.074
| 0.074
|
| 0.074
| 0.074
| 0.074
| 0.074
| 0.074
|-
| Sprains
| 0.064
| 0.064
| 0.064
| 0.064
| 0.064
|
| 0.064
| 0.064
| 0.064
| 0.064
| 0.064
|-
| Intracranial injury
|
|
|
|
|
|
|
|
|
|
|
|-
| Short term
| 0.359
| 0.359
| 0.359
| 0.359
| 0.359
|
| 0.359
| 0.359
| 0.359
| 0.359
| 0.359
|-
| Long term
| 0.359
| 0.359
| 0.359
| 0.359
| 0.359
|
| 0.359
| 0.359
| 0.359
| 0.359
| 0.359
|-
| Internal injuries
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.208
| 0.208
| 0.208
| 0.208
| 0.208
|-
| Open wound
| 0.108
| 0.108
| 0.108
| 0.108
| 0.108
|
| 0.108
| 0.108
| 0.108
| 0.108
| 0.108
|-
| Injury to eyes
| 0.354
| 0.354
| 0.354
| 0.354
| 0.354
|
| 0.301
| 0.300
| 0.299
| 0.299
| 0.299
|-
| Amputations
|
|
|
|
|
|
|
|
|
|
|
|-
| Thumb
| 0.165
| 0.165
| 0.165
| 0.165
| 0.165
|
| 0.165
| 0.165
| 0.165
| 0.165
| 0.165
|-
| Finger
| 0.102
| 0.102
| 0.102
| 0.102
| 0.102
|
| 0.102
| 0.102
| 0.102
| 0.102
| 0.102
|-
| Arm
| 0.102
| 0.102
| 0.102
| 0.102
| 0.102
|
| 0.102
| 0.102
| 0.102
| 0.102
| 0.102
|-
| Toe
| 0.078
| 0.078
| 0.078
| 0.078
| 0.078
|
| 0.064
| 0.064
| 0.064
| 0.064
| 0.064
|-
| Foot
| 0.300
| 0.300
| 0.300
| 0.300
| 0.300
|
| 0.300
| 0.300
| 0.300
| 0.300
| 0.300
|-
| Leg
| 0.300
| 0.300
| 0.300
| 0.300
| 0.300
|
| 0.300
| 0.300
| 0.300
| 0.300
| 0.300
|-
| Crushing
| 0.218
| 0.218
| 0.218
| 0.218
| 0.218
|
| 0.218
| 0.218
| 0.218
| 0.218
| 0.218
|-
| Burns
|
|
|
|
|
|
|
|
|
|
|
|-
| &lt;20% -- Short term
| 0.186
| 0.186
| 0.186
| 0.186
| 0.186
|
| 0.158
| 0.158
| 0.158
| 0.158
| 0.158
|-
| &lt;20% -- Long term
| 0.041
| 0.041
| 0.041
| 0.041
| 0.041
|
| 0.011
| 0.011
| 0.011
| 0.011
| 0.011
|-
| &gt;20% and &lt;60% -- Short term
| 0.469
| 0.469
| 0.469
| 0.469
| 0.469
|
| 0.441
| 0.441
| 0.441
| 0.441
| 0.441
|-
| &gt;20% and &lt;60% -- Long term
| 0.255
| 0.255
| 0.255
| 0.255
| 0.255
|
| 0.255
| 0.255
| 0.255
| 0.255
| 0.255
|-
| &gt;60% -- Short term
| 0.469
| 0.469
| 0.469
| 0.469
| 0.469
|
| 0.441
| 0.441
| 0.441
| 0.441
| 0.441
|-
| &gt;60% -- Long term
| 0.255
| 0.255
| 0.255
| 0.255
| 0.255
|
| 0.255
| 0.255
| 0.255
| 0.255
| 0.255
|-
| Injured nerves
| 0.078
| 0.078
| 0.078
| 0.078
| 0.078
|
| 0.064
| 0.064
| 0.064
| 0.064
| 0.064
|}


Figure 1. An illustrative graph of the severity weights for different cancers
[[Image:Cancer DALY01.jpg]]
==See also==
* WHO report describing DALYs and presents disability weights: Murray CJL, Lopez AD, eds. 1996. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Cambridge, Harvard School of Public Health on behalf of the World Health Organization and the World Bank.
* An update of the disability weights [http://www.who.int/healthinfo/global_burden_disease/GBD2004_DisabilityWeights.pdf]
* Data by regions (European), for example YLD (years of life lived with the disease) [http://www.who.int/healthinfo/global_burden_disease/estimates_regional/en/]
* Dutch disability weights [http://www.rivm.nl/vtv/object_document/o1676n18840.html] (Available only in Dutch).
==References==
==References==


<references/>
<references/>
[[Category:THL publications 2010]]
[[Category:THL publications 2010]]

Latest revision as of 10:08, 26 August 2013



Disability weights describe the weights that are given to different diseases in the calculation of disability-adjusted life years (DALY).

Question

What are disability weights for different disases, and how should they be used in calculating burden of disease?

Answer

This code can be used on this page to calculate YLD (years of life under disease). The code can also be copied to another page in Opasnet. It runs on R, so it is also possible to copy and use it outside the Opasnet workspace.

How many cases of disease are there? (#):

What is the duration of disease? (years):

+ Show code

NOTE! Old official WHO disability weights were used in a previous version of this page. The current version uses disability weights from Salomon (Salomon et al., Lancet 2012-2013

[1]).

D↷

Rationale

Data

Disability weights are obtained by posing two different Person Trade-Off (PTO) questions to expert panels

  • Question 1 compares life extensions for disabled and healthy people
  • Question 2 compares cures for illness with extension of life

Ideally, these values should be derived from empirical data among representative populations. Combining the answers to these questions results in an average disability weight. Usually, these weights are presented as a fixed parameter, without a confidence interval or other type of distribution.

Arguments defending this approach include:

  • DALY weights are an intrinsically subjective value for which no "true estimate" exists. They should be treated as a normative value, which does not need further uncertainty intervals.
  • Uncertainty in very small DALY weights (for less severe effects) affects overall outcomes of DALY calculations much more than uncertainty in large disability weights. This is a "flaw" of the method: if health would be defined as 1 and death as 0 (as is being done with QALYs), the more severe outcomes would have more overall uncertainty. The uncertainty is greatest for the smallest disability weights and narrows as more severe weights are attained (figure 5.16

[2] ).This provides a skewed image. In order to avoid this, distributions should not be used. Another solution might be to normalize the weights. D↷

Arguments opposing this approach include:

  • Estimates of DALY weights differ between experts, so this variation should be presented in the overall distribution of these weights.

Including uncertainty intervals of disability weights will probably not affect the ranking of overall disease burden estimates very significantly (WHO GBD study). However, it will affect the confidence interval of individual estimates.



List of data files or sources:

Disability weights

Comment: ICD (ICD-10) codes should be added for indexing/OH 19 May 2009

The previous version of disability weights is archived. The data was from [2] (WHO → GBD → Tools → National tools → NATIONAL BURDEN OF DISEASE SUPPLEMENTARY FILES → Disability weights [xls 313kb]).

Disability weights based on IHME (Salomon et al., Lancet 13 Dec, 2012):

Disability weights: Difference between revisions(fraction)
ObsDiagnosisWeight
1Infectious disease: acute episode, mild0.005 (0.002-0.011)
2Infectious disease: acute episode, moderate0.053 (0.033-0.081)
3Infectious disease: acute episode, severe0.210 (0.139-0.298)
4Infectious disease: post-acute consequences (fatigue, emotional lability, insomnia)0.254 (0.170-0.355)
5Diarrhoea: mild0.061 (0.036-0.093)
6Diarrhoea: moderate0.202 (0.133-0.299)
7Diarrhoea: severe0.281 (0.184-0.399)
8Epididymo-orchitis0.097 (0.063-0.137)
9Herpes zoster0.061 (0.039-0.094)
10HIV: symptomatic, pre-AIDS0.221 (0.146-0.310)
11HIV/AIDS: receiving antiretroviral treatment0.053 (0.034-0.079)
12AIDS: not receiving antiretroviral treatment0.547 (0.382-0.715)
13Intestinal nematode infections: symptomatic0.030 (0.016-0.048)
14Lymphatic filariasis: symptomatic0.110 (0.073-0.157)
15Ear pain0.018 (0.009-0.031)
16Tuberculosis: without HIV infection0.331 (0.222- 0.450)
17Tuberculosis: with HIV infection0.399 (0.267-0.547)
18Cancer: diagnosis and primary therapy0.294 (0.199-0.411)
19Cancer: metastatic0.484 (0.330-0.643)
20Mastectomy0.038 (0.022-0.059)
21Stoma0.086 (0.055-0.131)
22Terminal phase: with medication (for cancers, end-stage kidney or liver disease)0.508 (0.348-0.670)
23Terminal phase: without medication (for cancers, end-stage kidney or liver disease)0.519 (0.356-0.683)
24Acute myocardial infarction: days 1-20.422 (0.284-0.566)
25Acute myocardial infarction: days 3-280.056 (0.035-0.082)
26Angina pectoris: mild0.037 (0.022-0.058)
27Angina pectoris: moderate0.066 (0.043-0.095)
28Angina pectoris: severe0.167 (0.109-0.234)
29Cardiac conduction disorders and cardiac dysrhythmias0.145 (0.097-0.205)
30Claudication0.016 (0.008-0.028)
31Heart failure: mild0.037 (0.021-0.058)
32Heart failure: moderate0.070 (0.044-0.102)
33Heart failure: severe0.186 (0.128-0.261)
34Stroke: long-term consequences, mild0.021 (0.011-0.037)
35Stroke: long-term consequences, moderate0.076 (0.050-0.110)
36Stroke: long-term consequences, moderate plus cognition problems0.312 (0.211-0.433)
37Stroke: long-term consequences, severe0.539 (0.363-0.705)
38Stroke: long-term consequences, severe plus cognition problems0.567 (0.394-0.738)
39Diabetic foot0.023 (0.012-0.039)
40Diabetic neuropathy0.099 (0.066-0.145)
41Chronic kidney disease (stage IV)0.105 (0.069-0.154)
42End-stage renal disease: with kidney transplant0.027 (0.015-0.043)
43End-stage renal disease: on dialysis0.573 (0.397-0.749)
44Decompensated cirrhosis of the liver0.194 (0.127-0.273)
45Gastric bleeding0.323 (0.214-0.461)
46Crohn's disease or ulcerative colitis0.225 (0.152-0.314)
47Benign prostatic hypertrophy: symptomatic0.070 (0.046-0.102)
48Urinary incontinence0.142 (0.094-0.204)
49Impotence0.019 (0.010-0.034)
50Infertility: primary0.011 (0.005-0.021)
51Infertility: secondary0.006 (0.002-0.013)
52Asthma: controlled0.009 (0.004-0.018)
53Asthma: partially controlled0.027 (0.015-0.045)
54Asthma: uncontrolled0.132 (0.087-0.190)
55COPD and other chronic respiratory diseases: mild0.015 (0.007-0.028)
56COPD and other chronic respiratory diseases: moderate0.192 (0.129-0.271)
57COPD and other chronic respiratory diseases: severe0.383 (0.259-0.528)
58Dementia: mild0.082 (0.055-0.117)
59Dementia: moderate0.346 (0.233-0.475)
60Dementia: severe0.438 (0.299-0.584)
61Headache: migraine0.433 (0.287-0.593)
62Headache: tension-type0.040 (0.025-0.062)
63Multiple sclerosis: mild0.198 (0.137-0.278)
64Multiple sclerosis: moderate0.445 (0.303-0.593)
65Multiple sclerosis: severe0.707 (0.522-0.857)
66Epilepsy: treated, seizure free0.072 (0.047-0.106)
67Epilepsy: treated, with recent seizures0.319 (0.211-0.445)
68Epilepsy: untreated0.420 (0.279-0.572)
69Epilepsy: severe0.657 (0.464-0.827)
70Parkinson's disease: mild0.011 (0.005-0.021)
71Parkinson's disease: moderate0.263 (0.179-0.360)
72Parkinson's disease: severe0.549 (0.383-0.711)
73Alcohol use disorder: mild0.259 (0.176-0.359)
74Alcohol use disorder: moderate0.388 (0.262-0.529)
75Alcohol use disorder: severe0.549 (0.384-0.708)
76Fetal alcohol syndrome: mild0.017 (0.008-0.032)
77Fetal alcohol syndrome: moderate0.057 (0.036-0.087)
78Fetal alcohol syndrome: severe0.177 (0.117-0.255)
79Cannabis dependence0.329 (0.223-0.455)
80Amphetamine dependence0.353 (0.215-0.525)
81Cocaine dependence0.376 (0.235-0.553)
82Heroin and other opioid dependence0.641 (0.459-0.803)
83Anxiety disorders: mild0.030 (0.017-0.048)
84Anxiety disorders: moderate0.149 (0.101-0.210)
85Anxiety disorders: severe0.523 (0.365-0.684)
86Major depressive disorder: mild episode0.159 (0.107-0.223)
87Major depressive disorder: moderate episode0.406 (0.276-0.551)
88Major depressive disorder: severe episode0.655 (0.469-0.816)
89Bipolar disorder: manic episode0.480 (0.323-0.642)
90Bipolar disorder: residual state0.035 (0.021-0.055)
91Schizophrenia: acute state0.756 (0.571-0.894)
92Schizophrenia: residual state0.576 (0.399-0.756)
93Anorexia nervosa0.223 (0.151-0.313)
94Bulimia nervosa0.223 (0.150-0.310)
95Attention-deficit hyperactivity disorder0.049 (0.031-0.074)
96Conduct disorder0.236 (0.154-0.337)
97Asperger's syndrome0.110 (0.073-0.157)
98Autism0.259 (0.177-0.362)
99Intellectual disability: mild0.031 (0.018-0.049)
100Intellectual disability: moderate0.080 (0.053-0.114)
101Intellectual disability: severe0.126 (0.085-0.176)
102Intellectual disability: profound0.157 (0.107-0.221)
103Hearing loss: mild0.005 (0.002-0.012)
104Hearing loss: moderate0.023 (0.013-0.038)
105Hearing loss: severe0.032 (0.018-0.051)
106Hearing loss: profound0.031 (0.018-0.049)
107Hearing loss: complete0.033 (0.020-0.052)
108Hearing loss: mild, with ringing0.038 (0.024-0.058)
109Hearing loss: moderate, with ringing0.058 (0.037-0.085)
110Hearing loss: severe, with ringing0.065 (0.041-0.094)
111Hearing loss: profound, with ringing0.088 (0.058-0.127)
112Hearing loss: complete, with ringing0.092 (0.061-0.134)
113Distance vision: mild impairment0.004 (0.001-0.010)
114Distance vision: moderate impairment0.033 (0.020-0.052)
115Distance vision: severe impairment0.191 (0.129-0.269)
116Distance vision blindness0.195 (0.132-0.272)
117Near vision impairment0.013 (0.006-0.024)
118Low back pain: acute, without leg pain0.269 (0.184-0.373)
119Low back pain: acute, with leg pain0.322 (0.219-0.447)
120Low back pain: chronic, without leg pain0.366 (0.248-0.499)
121Low back pain: chronic, with leg pain0.374 (0.252-0.506)
122Neck pain: acute, mild0.040 (0.023-0.064)
123Neck pain: acute, severe0.221 (0.150-0.305)
124Neck pain: chronic, mild0.101 (0.067-0.149)
125Neck pain: chronic, severe0.286 (0.197-0.398)
126Musculoskeletal problems: legs, mild0.023 (0.013-0.039)
127Musculoskeletal problems: legs, moderate0.079 (0.053-0.115)
128Musculoskeletal problems: legs, severe0.171 (0.117-0.240)
129Musculoskeletal problems: arms, mild0.024 (0.014-0.041)
130Musculoskeletal problems: arms, moderate0.114 (0.077-0.159)
131Musculoskeletal problems: generalised, moderate0.292 (0.197-0.410)
132Musculoskeletal problems: generalised, severe0.606 (0.421-0.771)
133Gout: acute0.293 (0.198-0.404)
134Amputation of finger(s), excluding thumb: long term, with treatment0.030 (0.018-0.048)
135Amputation of thumb: long term0.013 (0.006-0.025)
136Amputation of one arm: long term, with or without treatment0.130 (0.088-0.185)
137Amputation of both arms: long term, with treatment0.044 (0.028-0.067)
138Amputation of both arms: long term, without treatment0.359 (0.242-0.497)
139Amputation of toe0.008 (0.003-0.017)
140Amputation of one leg: long term, withtreatment0.021 (0.011-0.035)
141Amputation of one leg: long term, without treatment0.164 (0.111-0.229)
142Amputation of both legs: long term, with treatment0.051 (0.032-0.076)
143Amputation of both legs: long term, without treatment0.494 (0.341-0.654)
144Burns of <20% total surface area without lower airway burns: short term, with or without treatment0.096 (0.062-0.140)
145Burns of <20% total surface area or <10% total surface area if head or neck, or hands or wrist involved: long term, with or without treatment0.018 (0.010-0.032)
146Burns of ≥20% total surface area: short term, with or without treatment0.333 (0.220-0.472)
147Burns of ≥20% total surface area or ≥10% total surface area if head or neck, or hands or wrist involved: long term, with treatment0.127 (0.086-0.183)
148Burns of ≥20% total surface area or ≥10% total surface area if head or neck, or hands or wrist involved: long term, without treatment0.438 (0.298-0.588)
149Lower airway burns: with or without treatment0.373 (0.248-0.521)
150Crush injury: short or long term, with or without treatment0.145 (0.093-0.211)
151Dislocation of hip: long term, with or without treatment0.017 (0.008-0.030)
152Dislocation of knee: long term, with or without treatment0.129 (0.087-0.178)
153Dislocation of shoulder: long term, with or without treatment0.080 (0.053-0.116)
154Other injuries of muscle and tendon (includes sprains, strains, and dislocations other than shoulder, knee, or hip)0.009 (0.004-0.018)
155Drowning and non-fatal submersion: short or long term, with or without treatment0.288 (0.191-0.403)
156Fracture of clavicle, scapula, or humerus: short or long term, with or without treatment0.053 (0.033-0.080)
157Fracture of face bone: short or long term, with or without treatment0.173 (0.111- 0.257)
158Fracture of foot bones: short term, with or without treatment0.033 (0.019-0.053)
159Fracture of foot bones: long term, without treatment0.033 (0.019-0.052)
160Fracture of hand: short term, with or without treatment0.025 (0.013-0.043)
161Fracture of hand: long term, without treatment0.016 (0.008-0.028)
162Fracture of neck of femur: short term, with or without treatment0.308 (0.205-0.439)
163Fracture of neck of femur: long term, with treatment0.072 (0.047-0.105)
164Fracture of neck of femur: long term, without treatment0.388 (0.261-0.532)
165Fracture other than neck of femur: short term, with or without treatment0.192 (0.121-0.280)
166Fracture other than neck of femur: long term, without treatment0.053 (0.035-0.079)
167Fracture of patella, tibia or fibula, or ankle: short term, with or without treatment0.087 (0.055-0.127)
168Fracture of patella, tibia or fibula, or ankle: long term, with or without treatment0.070 (0.047-0.102)
169Fracture of pelvis: short term0.390 (0.257-0.545)
170Fracture of pelvis: long term0.194 (0.132-0.272)
171Fracture of radius or ulna: short term, with or without treatment0.065 (0.040-0.101)
172Fracture of radius or ulna: long term, without treatment0.050 (0.032-0.075)
173Fracture of skull: short or long term, with or without treatment0.073 (0.046-0.109)
174Fracture of sternum or fracture of one or two ribs: short term, with or without treatment0.150 (0.098-0.215)
175Fracture of vertebral column: short or long term, with or without treatment0.132 (0.085-0.195)
176Fractures: treated, long term0.003 (0.001-0.008)
177Injured nerves: short term0.065 (0.040-0.096)
178Injured nerves: long term0.136 (0.092-0.189)
179Injury to eyes: short term0.079 (0.050-0.118)
180Severe traumatic brain injury: short term, with or without treatment0.235 (0.156-0.331)
181Traumatic brain injury: long-term consequences, minor, with or without treatment0.106 (0.072-0.147)
182Traumatic brain injury: long-term consequences, moderate, with or without treatment0.224 (0.153-0.314)
183Traumatic brain injury: long-term consequences, severe, with or without treatment0.625 (0.444-0.789)
184Open wound: short term, with or without treatment0.005 (0.002-0.013)
185Poisoning: short term, with or without treatment0.171 (0.116-0.239)
186Severe chest injury: long term, with or without treatment0.056 (0.036-0.082)
187Severe chest injury: short term, with or without treatment0.352 (0.229-0.484)
188Spinal cord lesion below neck: treated0.047 (0.029-0.072)
189Spinal cord lesion below neck: untreated0.440 (0.290-0.588)
190Spinal cord lesion at neck: treated0.369 (0.243-0.513)
191Spinal cord lesion at neck: untreated0.673 (0.475-0.837)
192Abdominopelvic problem: mild0.012 (0.005-0.023)
193Abdominopelvic problem: moderate0.123 (0.083-0.176)
194Abdominopelvic problem: severe0.326 (0.219-0.451)
195Anaemia: mild0.005 (0.002-0.011)
196Anaemia: moderate0.058 (0.038-0.086)
197Anaemia: severe0.164 (0.112-0.228)
198Periodontitis0.008 (0.003-0.017)
199Dental caries: symptomatic0.012 (0.005-0.023)
200Severe tooth loss0.072 (0.048-0.103)
201Disfigurement: level 10.013 (0.006-0.025)
202Disfigurement: level 20.072 (0.048-0.103)
203Disfigurement: level 30.398 (0.271-0.543)
204Disfigurement: level 1 with itch or pain0.029 (0.016-0.048)
205Disfigurement: level 2, with itch or pain0.187 (0.125-0.264)
206Disfigurement: level 3, with itch or pain0.562 (0.394-0.725)
207Generic uncomplicated disease: worry and daily medication0.031 (0.017-0.050)
208Generic uncomplicated disease: anxiety about diagnosis0.054 (0.033-0.082)
209Iodine-deficiency goitre0.200 (0.134-0.283)
210Kwashiorkor0.055 (0.033-0.085)
211Severe wasting0.127 (0.081-0.183)
212Speech problems0.054 (0.034-0.081)
213Motor impairment: mild0.012 (0.005-0.022)
214Motor impairment: moderate0.076 (0.050-0.109)
215Motor impairment: severe0.377 (0.251-0.518)
216Motor plus cognitive impairments: mild0.054 (0.033-0.084)
217Motor plus cognitive impairments: moderate0.221 (0.141-0.314)
218Motor plus cognitive impairments: severe0.425 (0.286-0.587)
219Rectovaginal fistula0.492 (0.330-0.660)
220Vesicovaginal fistula0.338 (0.228-0.467)

See also

  • Global Burden of Disease Study
  • Disability-adjusted life years
  • Disability-adjusted life year in Wikipedia
  • WHO report describing DALYs and presents disability weights: Murray CJL, Lopez AD, eds. 1996. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Cambridge, Harvard School of Public Health on behalf of the World Health Organization and the World Bank.
  • An update of the disability weights [3]
  • Data by regions (European), for example YLD (years of life lived with the disease) [4]
  • Dutch disability weights [5] (Available only in Dutch)
  • Severity weights for noise outcomes

References

  1. Salomon JA, Vos T, Hogan DR, Gagnon M, Naghavi M et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet. 2013 Dec 15;380(9859):2129-43. doi:10.1016/S0140-6736(12)61680-8 .
  2. Colin D. Mathers, Joshua A. Salomon, Majid Ezzati, Stephen Begg, Stephen Vander Hoorn, and Alan D. Lopez, "Sensitivity and Uncertainty Analyses for Burden of Disease and Risk Factor Estimates." 2006. Global Burden of Disease and Risk Factors,ed. , 399-426. New York: Oxford University Press. DOI: 10.1596/978-0-8213-6262-4/Chpt-5.